<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id><journal-title-group><journal-title>Frontiers in Bioengineering and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2296-4185</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40013305</article-id><article-id pub-id-type="pmc">PMC11861087</article-id><article-id pub-id-type="publisher-id">1527854</article-id><article-id pub-id-type="doi">10.3389/fbioe.2025.1527854</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioengineering and Biotechnology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation</article-title><alt-title alt-title-type="left-running-head">Dutra Alves et al.</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fbioe.2025.1527854" ext-link-type="uri">10.3389/fbioe.2025.1527854</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dutra Alves</surname><given-names>Nathalia Silva</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Reigado</surname><given-names>Gustavo Roncoli</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Mayara</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Caldeira</surname><given-names>Izabela Daniel Sardinha</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Hernandes</surname><given-names>Henrique dos Santos</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Freitas-Marchi</surname><given-names>Bruna Leticia</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Zhivov</surname><given-names>Elina</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author"><name><surname>Chambergo</surname><given-names>Felipe Santiago</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Nunes</surname><given-names>Viviane Abreu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1789695/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Skin Physiology and Tissue Bioengineering</institution>, <institution>School of Arts, Sciences and Humanities</institution>, <institution>University of S&#x000e3;o Paulo</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Laboratory of Proteins and Biotechnology</institution>, <institution>School of Arts, Sciences and Humanities</institution>, <institution>University of S&#x000e3;o Paulo</institution>, <addr-line>S&#x000e3;o Paulo</addr-line>, <country>Brazil</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Laboratory of Organic Chemistry and Molecular Biology</institution>, <institution>University of Gothenburg</institution>, <addr-line>Gothenburg</addr-line>, <country>Sweden</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Wound Healing and Regenerative Medicine Research Program</institution>, <institution>Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery</institution>, <institution>University of Miami Miller Medical School</institution>, <addr-line>Miami</addr-line>, <addr-line>FL</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/192393/overview" ext-link-type="uri">Mary Murphy</ext-link>, University of Galway, Ireland</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/836738/overview" ext-link-type="uri">Xiao Long</ext-link>, Peking Union Medical College Hospital (CAMS), China</p><p>
<ext-link xlink:href="https://loop.frontiersin.org/people/1729728/overview" ext-link-type="uri">Manira Maarof</ext-link>, Universiti Kebangsaan Malaysia Medical Center (UKMMC), Malaysia</p></fn><corresp id="c001">*Correspondence: Viviane Abreu Nunes, <email>vanunes@ib.usp.br</email>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>1527854</elocation-id><history><date date-type="received"><day>13</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Dutra Alves, Reigado, Santos, Caldeira, Hernandes, Freitas-Marchi, Zhivov, Chambergo and Nunes.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Dutra Alves, Reigado, Santos, Caldeira, Hernandes, Freitas-Marchi, Zhivov, Chambergo and Nunes</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Significant progress has been made in regenerative medicine for skin repair and rejuvenation. This review examines core technologies including stem cell therapy, bioengineered skin substitutes, platelet-rich plasma (PRP), exosome-based therapies, and gene editing techniques like CRISPR. These methods hold promise for treating a range of conditions, from chronic wounds and burns to age-related skin changes and genetic disorders. Challenges remain in optimizing these therapies for broader accessibility and ensuring long-term safety and efficacy.</p></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>
<graphic xlink:href="FBIOE_fbioe-2025-1527854_wc_abs.jpg" position="float"/>
</p></abstract><kwd-group><kwd>skin regeneration</kwd><kwd>rejuvenation</kwd><kwd>regenerative medicine</kwd><kwd>stem cells</kwd><kwd>bioengineered skin substitutes</kwd><kwd>wound healing</kwd><kwd>chronic wounds</kwd><kwd>burns</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo &#x02013; FAPESP (2019/11693-0).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Tissue Engineering and Regenerative Medicine</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>1 Data collection and inclusion/exclusion criteria</title><p>This review systematically analyzed articles published in English from 2015 to 2024 focusing on regenerative medicine approaches for skin regeneration and rejuvenation. Searches were conducted using PubMed, Scopus, and Web of Science databases. Keywords included combinations of &#x0201c;skin regeneration&#x0201d;, &#x0201c;skin rejuvenation&#x0201d;, &#x0201c;regenerative medicine&#x0201d;, and specific treatment modalities (e.g., &#x0201c;stem cell therapy&#x0201d;, &#x0201c;platelet-rich plasma&#x0201d;, &#x0201c;exosomes&#x0201d;). Studies were included if they presented original research or comprehensive reviews related to the specified topic. Exclusion criteria included studies not published in English, those focusing solely on animal models without human relevance, and those not meeting minimum methodological quality standards such as lack of adequate controls, small sample sizes.</p></sec><sec id="s2"><title>2 Skin regeneration and rejuvenation</title><p>Regenerative medicine is a developing field focused on the repair, rejuvenation, replacement, or regeneration of tissues and organs to reestablish normal function (<xref rid="B108" ref-type="bibr">Mao and Mooney, 2015</xref>; <xref rid="B147" ref-type="bibr">Sampogna et al., 2015</xref>; <xref rid="B72" ref-type="bibr">Jafarzadeh et al., 2024</xref>). In the context of skin, regenerative medicine offers innovative approaches to healing (<xref rid="B151" ref-type="bibr">Shimizu et al., 2022</xref>; <xref rid="B105" ref-type="bibr">Mahajan et al., 2024</xref>) and rejuvenating the skin (<xref rid="B75" ref-type="bibr">Jo et al., 2021</xref>; <xref rid="B161" ref-type="bibr">Taub, 2024</xref>), the body&#x02019;s largest organ and serves as the first line of defense.</p><p>The skin is a complex, multi-layered organ composed of the epidermis (outer layer), dermis (middle layer), and hypodermis (subcutaneous tissue). It possesses several critical functions such as a) barrier protection against pathogens, ultraviolet radiation (UV), and physical injury; b) temperature regulation, maintaining body temperature through sweat production and blood vessel dilation or constriction, c) sensory perception, since it contains nerve endings and d) immune defense, where host immune cells protect against infections and participate in wound healing (<xref rid="B183" ref-type="bibr">Yousef et al., 2024</xref>).</p><p>Skin can be damaged by several factors, including injury, diseases, aging, and environmental stressors (<xref rid="B125" ref-type="bibr">Parrado et al., 2019</xref>; <xref rid="B12" ref-type="bibr">Arabpour et al., 2024</xref>). Traditional treatments often focus on managing symptoms rather than focusing on the underlying damage. On the other hand, regenerative medicine for skin focuses on repairing or replacement of damaged skin tissue, restoring the skin normal function and appearance by promoting the regeneration of the tissue (<xref rid="B49" ref-type="bibr">Fadilah et al., 2022</xref>). Innovative techniques, including stem cell therapy, tissue engineering, and growth factors, have been developed to address conditions such as chronic wounds, burns, scars, chronic ulcers, and aged skin (<xref rid="B151" ref-type="bibr">Shimizu et al., 2022</xref>). These approaches aim to accelerate healing, minimize scarring, and restore skin integrity (<xref rid="B49" ref-type="bibr">Fadilah et al., 2022</xref>).</p><p>Specifically, chronic wounds, such as diabetic foot ulcers (DFU), venous leg (VLU) or pressure ulcers, can be difficult to treat and often fail to heal with conventional methods (<xref rid="B55" ref-type="bibr">Frykberg and Banks, 2015</xref>; <xref rid="B120" ref-type="bibr">OuYang et al., 2023</xref>). Regenerative approaches such as stem cell therapy and bioengineered skin can promote faster and effective healing in DFU (<xref rid="B31" ref-type="bibr">Chiu et al., 2023</xref>). Platelet-rich plasma (PRP), which is rich in growth factors, can be used to enhance healing and regeneration in chronic skin conditions where skin healing is impaired (<xref rid="B179" ref-type="bibr">Xu et al., 2020</xref>).</p><p>Also, severe burns can result in significant tissue loss and scarring. Traditional burn treatments often involve skin grafts, which can be painful and leave significant scarring (<xref rid="B32" ref-type="bibr">Chogan et al., 2023</xref>). On the other hand, regenerative medicine, requires advanced therapies like bioengineered skin grafts, stem cell treatments, exosome therapy, topical application of growth factors, such as Epidermal Growth Factor (EGF) and Platelet Derived Growth Factor (PDGF) directly to burn wounds, to promote faster and more effective healing (<xref rid="B32" ref-type="bibr">Chogan et al., 2023</xref>), reducing scarring, and improving functionality, elasticity, and sensitivity, as well as aesthetic outcomes. Additionally, advanced dressings and scaffolds are being proposed such as hydrogel dressings, which provide a moist environment that promotes healing and reduces pain. They can also be infused with growth factors, stem cells, or other regenerative agents to further enhance wound healing (<xref rid="B158" ref-type="bibr">Surowiecka et al., 2022</xref>). As far as burned skin, fractional CO<sub>2</sub> laser therapy can be applied to remodel scar tissue and improve the texture and elasticity of the skin. This therapy can also be combined with stem cells or growth factors, as treatments to enhance skin regeneration (<xref rid="B144" ref-type="bibr">Roohaninasab et al., 2023</xref>). In case of burns, many regenerative treatments, such as stem cell therapy can also be tailored to the individual patient, reducing the risk of immune rejection and improving outcomes (<xref rid="B102" ref-type="bibr">Lukomskyj et al., 2022</xref>).</p><p>Chronic skin conditions like psoriasis, eczema, and vitiligo often present significant challenges in terms of management and treatment. Regenerative medicine offers new perspectives by targeting the underlying causes of these diseases and promoting long-term regeneration of skin (<xref rid="B121" ref-type="bibr">Paganelli et al., 2020</xref>; <xref rid="B38" ref-type="bibr">Daltro et al., 2020</xref>; <xref rid="B124" ref-type="bibr">Park et al., 2019</xref>; <xref rid="B15" ref-type="bibr">Bellei et al., 2022</xref>). It has been shown, for example, that mesenchymal stem cells (MSCs) can reduce the hyperproliferation of skin cells and modulate the immune response, potentially leading to remission of symptoms in autoimmune-related skin conditions like psoriasis and eczema (<xref rid="B152" ref-type="bibr">Shin et al., 2017</xref>; <xref rid="B38" ref-type="bibr">Daltro et al., 2020</xref>; <xref rid="B42" ref-type="bibr">Diotallevi et al., 2022</xref>). Also, exosomes can be topically applied or injected into affected areas to improve skin health and reduce the symptoms of chronic skin conditions (<xref rid="B170" ref-type="bibr">Wang et al., 2019</xref>; <xref rid="B50" ref-type="bibr">Farabi et al., 2024</xref>). In vitiligo, exosomes may help restore pigmentation by stimulating melanogenesis and melanocyte-stimulating factors (<xref rid="B174" ref-type="bibr">Wong et al., 2020</xref>). Gene therapy is another modality that offers a promising approach to correcting the genetic mutations underlying chronic skin diseases. In conditions like epidermolysis bullosa, a severe blistering disorder, gene therapy can be used to restore functional genes in skin cells, potentially improving skin integrity and improving skin integrity and reducing blister formation (<xref rid="B19" ref-type="bibr">Bischof et al., 2024</xref>). In addition, CRISPR/Cas9, a gene-editing technology has the potential to correct mutations at the DNA level, a potential solution for certain genetic skin diseases (<xref rid="B2" ref-type="bibr">Abdelnour et al., 2021</xref>).</p><p>Finally, skin aging, a complex interplay of internal and external factors, can now be targeted with regenerative medicine (<xref rid="B66" ref-type="bibr">He et al., 2023</xref>). Since skin health is considered one of the main factors associated with welfare and the perception of health in humans, numerous anti-aging strategies have been developed and proposed (<xref rid="B56" ref-type="bibr">Ganceviciene et al., 2012</xref>). In the context of regenerative medicine and skin rejuvenation, anti-aging therapies focus on reversing or slowing down the signs of skin aging, which includes wrinkles, loss of elasticity, pigmentation, and thinning. The aim is to repair damaged skin, promote and/or stimulate collagen production, and restore young skin features (<xref rid="B174" ref-type="bibr">Wong et al., 2020</xref>; <xref rid="B143" ref-type="bibr">Ribaudo and Gianoncelli, 2023</xref>).</p><p>Given stem cells&#x02019; remarkable potential to differentiate into various cell types, they can be used to rejuvenate tissues and organs, enhancing their regenerative capacity (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>). Mesenchymal stem cells (MSCs) are not only capable of differentiating into skin cells but also are able to release growth factors and cytokines that enhance collagen synthesis and skin tissue regeneration. In this way, stem cell-based treatments are being explored for reducing wrinkles, improving skin elasticity, and treating scars (<xref rid="B75" ref-type="bibr">Jo et al., 2021</xref>). Also, adipose-derived stem cells (ADSCs) can be harvested from fat tissue and used in skin rejuvenation procedures, specifically ADSCs injected into areas of the face to restore volume and improve skin texture (<xref rid="B157" ref-type="bibr">Surowiecka and Stru&#x0017c;yna, 2022</xref>). Exosomes from stem cells have been shown to be particularly effective in promoting healing after procedures like laser therapy or microneedling, as they can accelerate skin regeneration (<xref rid="B135" ref-type="bibr">Prasai et al., 2022</xref>). In skin care, topical growth factors such as EGF and transforming growth factor-beta (TGF-&#x003b2;) or injected formulations can stimulate collagen synthesis, accelerate wound healing, and reduce the appearance of fine lines (<xref rid="B66" ref-type="bibr">He et al., 2023</xref>). In the same line, studies suggest that PRP can improve fine lines, wrinkles, and overall skin texture by promoting cellular repair and enhancing skin regeneration (<xref rid="B128" ref-type="bibr">Phoebe et al., 2024</xref>). Lately, gene editing tools such as CRISPR are being explored to repair age-related genetic damage (<xref rid="B185" ref-type="bibr">Yu et al., 2022</xref>) as well as some therapies targeting genes associated with aging, like telomerase activation, have been proposed to extend the lifespan of cells (<xref rid="B163" ref-type="bibr">Tenchov et al., 2024</xref>). Finally, advances in 3D bioprinting and tissue scaffolds are enabling the development of engineered skin substitutes for cosmetic applications (<xref rid="B133" ref-type="bibr">Pleguezuelos-Beltr&#x000e1;n et al., 2024</xref>). These skin substitutes can provide a platform for delivering stem cells or growth factors to damaged skin, promoting regeneration and rejuvenation.</p><p>Skin regenerative medicine generally encompasses two key approaches: cell-based and cell-free therapies. These include stem cell therapy, platelet-rich plasma (PRP), growth factors, cytokines, wound dressings, gene therapy, and tissue engineering, encompassing the use of biomaterials, skin grafts, bioengineered skin substitutes, and 3D bioprinting.</p></sec><sec id="s3"><title>3 Cell-based therapies</title><sec id="s3-1"><title>3.1 Stem cells</title><p>Stem cells are undifferentiated cells with the ability to self-replicate, self-renewal, homing and plasticity potential. They can differentiate into various cell types, such as nerve cells, cardiomyocytes, liver cells and skin cells (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>). They possess anti-inflammatory properties, promote epithelial cell proliferation, inhibit wound scarring, maintain homeostasis, repair tissue injuries, and accelerate healing (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="B81" ref-type="bibr">Khandpur et al., 2021</xref>; <xref rid="B188" ref-type="bibr">Zhang and Huang, 2023</xref>). Stem cells also secrete bioactive molecules, including growth factors, cytokines, chemokines and exosomes, which are responsible for the paracrine effects of these cells in bone tissue and nervous system regeneration, as well as in wound healing and endothelial cells (<xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>; <xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>).</p><p>There are different sources for using stem cells in regenerative medicine classified according to their differentiation potential (<xref rid="B81" ref-type="bibr">Khandpur et al., 2021</xref>), including embryonic stem cells (ESCs), umbilical cord mesenchymal stem cells (UCMSCs), induced pluripotent stem cells (iPSCs), MSCs, ADSCs and bone marrow mesenchymal stem cells (BMMSC) (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="B150" ref-type="bibr">Semsarzadeh and Khetarpal, 2022</xref>; <xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>).</p><p>MSCs are originated from the mesoderm and ectoderm, and can differentiate into various cell types, such as osteocytes, chondrocytes, adipocytes, neurons and endothelial cells (<xref rid="B104" ref-type="bibr">Ma et al., 2023</xref>; <xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>). Additionally, MSCs can be found in bone marrow, adipose tissue, synovial tissue, muscle, lung, liver, and umbilical cord blood (<xref rid="B81" ref-type="bibr">Khandpur et al., 2021</xref>; <xref rid="B71" ref-type="bibr">Huynh et al., 2022</xref>; <xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>). MSCs play a pivotal role in wound healing and exhibit additional functions including immunomodulation, anti-inflammatory and anti-apoptotic effects, and pro-angiogenic activity (<xref rid="B81" ref-type="bibr">Khandpur et al., 2021</xref>; <xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>).</p><p>Currently, there are several therapies using MSCs for the treatment of graft-versus-host disease, bone defects, ischemic heart failure, burns, autoimmune-related skin conditions, and diabetic foot (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>; <xref rid="B50" ref-type="bibr">Farabi et al., 2024</xref>). Since MSCs can differentiate into skin cells such as keratinocytes, fibroblasts, and endothelial cells, they can be used to enhance the healing process. This is not only due to their cell differentiation capabilities but also because of their crosstalk with macrophages, which play a role in the wound repair process (<xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>).</p><p>MSCs can be applied to burn injuries by inhibiting cellular inflammation through the release of anti-inflammatory cytokines. Additionally, MSCs exert paracrine effects that polarize macrophages from an inflammatory phenotype (M1) to a wound-healing phenotype (M2), promoting tissue repair and clearance (<xref rid="B104" ref-type="bibr">Ma et al., 2023</xref>; <xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>; <xref rid="B188" ref-type="bibr">Zhang and Huang, 2023</xref>). Moreover, they stimulate the formation of new blood vessels, which results in increased blood perfusion and the delivery of nutrients to affected areas, thereby accelerating the healing process (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="B150" ref-type="bibr">Semsarzadeh and Khetarpal, 2022</xref>). On top of that, MSCs improve the wound structure by secreting proteins that make up the extracellular matrix (ECM), such as collagen, elastin and fibronectin, enhancing the reconstruction of the dermis (<xref rid="B110" ref-type="bibr">Mazini et al., 2020</xref>; <xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>; <xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>).</p><p>Beyond that, bone marrow-derived MSCs can be used for scars reduction, anti-aging, and systemic sclerosis (<xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>). <xref rid="B36" ref-type="bibr">Conget et al. (2010)</xref> conducted a study in which they used these cells to treat two patients with severe generalized recessive dystrophic epidermolysis bullosa (EB). After 12 weeks of intradermal treatment, the ulcers healed completely, however this effect only lasted 4&#x000a0;months.</p><p>Another type of stem cells are the iPSCs. They are capable of differentiating into more cell types compared to MSCs, and they have the ability for unlimited self-renewal (<xref rid="B188" ref-type="bibr">Zhang and Huang, 2023</xref>). Studies show that these cells promote angiogenesis, perfusion, collagen deposition, and accelerate the natural healing process in murine models (<xref rid="B34" ref-type="bibr">Clayton et al., 2018</xref>; <xref rid="B50" ref-type="bibr">Farabi et al., 2024</xref>).</p><p>Besides MSCs and IPSCs, ADSCs are another promising cell type for regenerative therapy. ADSCs have shown potential applications in dermatology and aesthetics, including scar reduction, anti-aging, wrinkle reduction, and hair loss treatment (<xref rid="B81" ref-type="bibr">Khandpur et al., 2021</xref>; <xref rid="B156" ref-type="bibr">Suh et al., 2019</xref>; <xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>). <xref rid="B8" ref-type="bibr">Anderi et al. (2018)</xref> injected ADSCs, derived from liposuction, into 20 patients with alopecia areata, and after 6&#x000a0;months of follow-up, they observed a statistically significant difference in hair growth rates among all treated patients. Indeed, <xref rid="B187" ref-type="bibr">Zhang et al. (2014)</xref> evaluated the antioxidant effects of ADSCs in a mouse model and found that, after 28 days of injection, ADSCs reversed the aging phenotype, increased dermal thickness and collagen content, and enhanced skin vascular density. In addition, <xref rid="B29" ref-type="bibr">Chen et al. (2020)</xref> showed that ADSCs were effective in improving the appearance of the skin, particularly in reducing wrinkles in UV-damaged skin. These results highlight the paracrine effects of ADSCs in promoting skin rejuvenation.</p><p>Interestingly, <xref rid="B92" ref-type="bibr">Li et al. (2016)</xref> used the conditioned medium from ADSCs (ADSC-CM) to evaluate its effect on hypertrophic scars <italic>ex vivo</italic>, injecting them into rats. Through Western blotting, they analyzed key proteins involved in healing, such as collagen I, collagen III, and &#x003b1;-SMA (alpha-smooth muscle actin). The results showed that the use of ADSC-CM reduced collagen deposition in hypertrophic scar tissues and improved fibrosis in these tissues.</p><p>Not only ADSC-CM, but also conditioned medium from MSCs (MSC-CM) have been investigated to be used on regenerative medicine because it contains anti-apoptotic, anti-inflammatory and anti-aging substances. Because of that, there are pre-clinical studies using MSC-CM to show whether it influence on lung progenitor cell development or its paracrine effect influences tissue regeneration (<xref rid="B153" ref-type="bibr">Smolinsk&#x000e1; et al., 2023</xref>).</p><p>Yet another ADSCs derivative, nano-fat, obtained through a multi-step process involving mechanical digestion and filtration of fat tissue, has demonstrated several benefits, including reduced scar size, improved skin color, and enhanced overall skin quality (<xref rid="B156" ref-type="bibr">Suh et al., 2019</xref>; <xref rid="B64" ref-type="bibr">Hajimortezayi et al., 2024</xref>).</p><p>In addition, UCMSCs can also be used in regenerative medicine, having advantages over other types of stem cells because they are abundant, easy to collect, cause no harm to donors, have low immunogenicity, and high differentiation capacity (<xref rid="B74" ref-type="bibr">Jin et al., 2023</xref>; <xref rid="B91" ref-type="bibr">Li et al., 2024</xref>). They can be used for the treatment of cardiovascular diseases, liver diseases, degenerative muscle diseases, and autoimmune diseases (<xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>). They can also be used for treating burns and psoriasis vulgaris (<xref rid="B166" ref-type="bibr">Tran et al., 2023</xref>) and for treating chronic wounds, facial and body rejuvenation, even combination therapies with other biomaterials (<xref rid="B91" ref-type="bibr">Li et al., 2024</xref>).</p><p>The Stromal Vascular Fraction (SVF) is isolated from adipose tissue and contains various cell types, such as MSCs, endothelial cells, stromal cells, and immune cells (<xref rid="B157" ref-type="bibr">Surowiecka and Stru&#x0017c;yna, 2022</xref>). For example, in a pilot study, SVF was used for the treatment of alopecia, where a significant increase in hair growth in patients was observed (<xref rid="B150" ref-type="bibr">Semsarzadeh and Khetarpal, 2022</xref>).</p><p>While various stem cell types exist, extensive preclinical and clinical research suggests that mesenchymal stem cells (MSCs) and MSC-based products offer the most promising balance of safety and efficacy, with a low risk of tumor formation and minimal immune rejection (<xref rid="B68" ref-type="bibr">Hoang et al., 2022</xref>; <xref rid="B50" ref-type="bibr">Farabi et al., 2024</xref>). Despite their widespread use, MSCs have limitations, such as a decline in viability and activity with age (<xref rid="B176" ref-type="bibr">Wu et al., 2024</xref>).</p></sec><sec id="s3-2"><title>3.2 PRP&#x02013;platelet rich plasma</title><p>PRP was first used in 1954 to improve wound healing in dentistry (<xref rid="B84" ref-type="bibr">Kingsley, 1954</xref>). Since its inception, the application of PRP has grown significantly, becoming a valuable tool in tissue repair and regeneration across various medical fields. (<xref rid="B24" ref-type="bibr">Cecerska-Hery&#x00107; et al., 2022</xref>). The treatment is based on injections of the patient&#x02019;s own platelets highly concentrated in plasma and separated from other blood components by centrifugation cycles (<xref rid="B146" ref-type="bibr">Samadi et al., 2019</xref>; <xref rid="B132" ref-type="bibr">Pixley et al., 2023</xref>).</p><p>The peripheral blood contains at least five times fewer platelets than PRP. This increased platelet concentration in PRP enhances its potential for wound healing (<xref rid="B39" ref-type="bibr">Davies and Miron, 2024</xref>). Platelets are involved in a wide range of growth factors, proteins, cytokines and other biological agents that have effects in processes like cellular migration, proliferation, differentiation, angiogenesis, tissue regeneration and collagen synthesis (<xref rid="B130" ref-type="bibr">Pincelli et al., 2024</xref>). The variety of molecules derived from PRP enables efficient wound healing, as the healing process involves multiple molecules and complex pathways (<xref rid="B146" ref-type="bibr">Samadi et al., 2019</xref>; <xref rid="B39" ref-type="bibr">Davies and Miron, 2024</xref>).</p><p>Platelet-derived molecules could be secreted by &#x003b1;-granules, dense granules and lysosomes. Platelet derived growth factor (PDGF), insulin-like growth factor 1 (IGF-1), EGF, TGF-&#x003b2;, fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) are secreted from &#x003b1;-granules, in addition to adhesive proteins, coagulation factors, angiogenic regulators, cytokines and exosomes. They are the more abundant secretory granules and are responsible for releasing the greatest number of molecules with a direct effect on wound healing (<xref rid="B24" ref-type="bibr">Cecerska-Hery&#x00107; et al., 2022</xref>; <xref rid="B130" ref-type="bibr">Pincelli et al., 2024</xref>). On the other hand, dense granules contribute to platelet activation and subsequent release of &#x003b1;-granules constituents, in which it has been shown that PRP lysosomes functions participate in antimicrobial activity and the degradation of extracellular matrices (<xref rid="B48" ref-type="bibr">Everts et al., 2024</xref>).</p><p>The composition of PRP can vary depending on the preparation. It can be categorized as pure (P-PRP), leukocyte-poor (LP-PRP), leukocyte-rich (LR-PRP) or platelet-rich fibrin (PRF), considering the centrifugation time, speed and the presence or absence of non-autologous anticoagulants (<xref rid="B78" ref-type="bibr">Karimi and Rockwall, 2019</xref>; <xref rid="B48" ref-type="bibr">Everts et al., 2024</xref>). PRF specifically has gained prominence in regenerative medicine in recent years due to its benefits, such as the release of platelet-related therapeutic granules over a longer period and at a slower rate than PRP (<xref rid="B115" ref-type="bibr">Narayanaswamy et al., 2023</xref>). In this way, PRF also offers a valuable adjunct to both surgical and non-surgical interventions, demonstrating great potential for enhancing treatment outcomes.</p><p>PRP treatment offers several advantages, including low cost, ease of preparation, versatility, and safety. However, further research is necessary to standardize preparation procedures and establish regulations regarding the composition of PRP injectables. Additionally, the efficacy of PRP and its various categories remains uncertain in relation to specific diseases and clinical conditions (<xref rid="B47" ref-type="bibr">Everts et al., 2020</xref>; <xref rid="B24" ref-type="bibr">Cecerska-Hery&#x00107; et al., 2022</xref>; <xref rid="B130" ref-type="bibr">Pincelli et al., 2024</xref>).</p></sec></sec><sec id="s4"><title>4 Cell-free therapies</title><sec id="s4-1"><title>4.1 Exosomes for skin wound healing and rejuvenation</title><p>Micro-vesicles, currently known as exosomes, were first identified in 1983. Initially, exosomes were considered just a cell waste, however, later research revealed that exosomes play important roles in cell communication and signal transduction. As an alternative for cell-based therapies, exosomes emerged as potential tools for treating skin&#x02019;s conditions, such as improving wound healing and even skin rejuvenation. Since exosomes are small vesicles secreted by different cells, there are many possibilities for their isolation and use as an effective carrier for bioactive compounds or genetic material. Exosomes not only transport and protect molecules from degradation, but also exhibit biocompatibility, reducing the risk of immune reactions and tumorigenesis. In this way, clinical application of exosomes is a promising avenue for free-cell therapies (<xref rid="B63" ref-type="bibr">Hajialiasgary Najafabadi et al., 2024</xref>; <xref rid="B127" ref-type="bibr">Pe&#x000f1;a and Martin, 2024</xref>; <xref rid="B136" ref-type="bibr">Quan, 2023</xref>; <xref rid="B154" ref-type="bibr">Sonbhadra and Pandey, 2023</xref>; <xref rid="B189" ref-type="bibr">Zhou et al., 2023</xref>).</p><p>Exosomes are extracellular vesicles, approximately 30&#x02013;200&#x000a0;nm in size, which can be obtained from cell culture and that function as membrane-bound carriers of biomolecules and metabolites, reflecting their cellular origin. These vesicles, spherical in solution, exhibit a lipid bilayer structure, which decreases the risks of immune responses and provides protection of their cargo from degradation. Furthermore, exosomes pose a low risk of uncontrolled cell proliferation and differentiation, minimizing concerns related to tumorigenicity. Their ability to carry and deliver bioactive substances to cells makes exosome-based therapies a promising possibility for therapeutic applications like various skin conditions, including psoriasis, atopic dermatitis and vitiligo, as well as for promoting skin regeneration, such as in diabetic wound healing, hypertrophic scarring and keloid formation, and even for addressing skin aging (<xref rid="B61" ref-type="bibr">Gurung et al., 2021</xref>; <xref rid="B63" ref-type="bibr">Hajialiasgary Najafabadi et al., 2024</xref>; <xref rid="B184" ref-type="bibr">Yu et al., 2024</xref>).</p><p>Exosomes are ubiquitous in various body fluids, including serum, saliva, milk, cerebrospinal fluid, urine and semen. Among these, stem cell-derived exosomes have been extensively investigated for their potential role in mediating the biological effects of paracrine factors, particularly in wound healing (<xref rid="B189" ref-type="bibr">Zhou et al., 2023</xref>).</p><p>Tissue repair is a complex process involving initial clot formation, followed by inflammatory cell signaling, cell proliferation and remodeling. These phases overlap, each with its own purpose and time before the next starts. Mesenchymal stem cells exosomes (MSC-exos) derived from different tissues, like ADSC, hold a promise for cutaneous repair due to their ability to stimulate fibroblast activity. In the dermis, fibroblasts play a pivotal role in wound healing through collagen synthesis, making MSC-exos, which enhance fibroblast function, valuable contributors to the healing microenvironment and the promotion of wound repair. ADSC-derived exosomes demonstrate significant potential for treating diabetic wounds due to their ability to induce collagen I and III production in the early stages of healing, which can help prevent scar and keloid formation (<xref rid="B155" ref-type="bibr">Song et al., 2023</xref>; <xref rid="B189" ref-type="bibr">Zhou et al., 2023</xref>; <xref rid="B127" ref-type="bibr">Pe&#x000f1;a and Martin, 2024</xref>).</p><p>Data from an ECM loaded with ADSC-exosomes indicate that this combination is also a possible therapeutic approach for both normal and pathological wound healing. The results demonstrated that ECM-loaded exosomes promoted increased cell growth, cell migration, collagen deposition, and decreased inflammation <italic>in vivo</italic> (<xref rid="B155" ref-type="bibr">Song et al., 2023</xref>).</p><p>Moreover, given their role in wound healing, stem cell-derived exosomes could potentially be used to treat skin photoaging, a condition marked by uneven pigmentation and wrinkles (<xref rid="B63" ref-type="bibr">Hajialiasgary Najafabadi et al., 2024</xref>).</p><p>
<xref rid="B123" ref-type="bibr">Park et al. (2023)</xref> demonstrated that exosomes derived from human foreskin fibroblasts (BJ-5ta Exo) can mitigate oxidative stress by upregulating the expression of antioxidant genes CAT, SOD-1, SOD-2, and GPX. Additionally, BJ-5ta Exo promoted a decrease in programmed cell death and cell cycle arrest.</p><p>In addition, it was suggested that exosomes obtained from 3D culture of human dermal fibroblasts (HDFs) may be able to promote collagen synthesis and reduce skin inflammation. Data also revealed that 3D-HDF-exos, through tumor necrosis factor alpha (TNF-&#x003b1;) downregulation and TGF-&#x003b2; upregulation, promoted a procollagen type I increase while reducing matrix metalloproteinase-1 (MMP-1) expression. Given the age-related decline in HDF collagen production and repair, coupled with increased MMP-mediated ECM degradation, these findings suggest that exosomes may possess anti-aging properties (<xref rid="B178" ref-type="bibr">Xiong et al., 2021</xref>).</p><p>Given the abundance of exosomes in bovine milk, recent studies have explored the potential of milk-derived exosomes (MK-exo) as novel anti-aging compounds. These investigations have revealed that MK-exo can stimulate the expression of filaggrin and CD44 in keratinocytes, as well as hyaluronidase levels in fibroblasts. Furthermore, MK-exo protected collagen biosynthesis from UV-induced damage. Notably, these exosomes also stimulated increased cell migration rates in fibroblasts (<xref rid="B101" ref-type="bibr">Lu et al., 2024</xref>).</p><p>However, while exosomes demonstrate significant promise as therapeutic agents, several challenges must be addressed for their clinical application. These include standardizing isolation and analysis, ensuring safety and purity, and preserving exosome activity during preparation and storage (<xref rid="B101" ref-type="bibr">Lu et al., 2024</xref>; <xref rid="B142" ref-type="bibr">Rezaie et al., 2022</xref>).</p><p>Despite above stated challenges, exosomes, being versatile carriers of biomolecules, offer promise for clinical applications. Their biocompatibility, low risk of immune responses and tumorigenicity make them attractive candidates for treating diseases. In the context of skin, their potential to influence collagen synthesis and inflammation suggests their value for wound healing and skin rejuvenation. Future research should focus on exploring these possibilities and ensuring the safety of exosomes for medical use.</p></sec><sec id="s4-2"><title>4.2 Pharmaceuticals, growth factors, fillers, gene therapy</title><p>Dermal fillers, also known as facial fillers, are soft, gel-like substances injected beneath the skin. Over time, the loss of soft tissue volume, fat redistribution, reduced skin elasticity, and thickness contribute to the formation of wrinkles and folds characteristic of aging. In this context, injectable fillers are an option for treating wrinkles, scars, folds, and areas under the skin lacking volume (<xref rid="B23" ref-type="bibr">Callan et al., 2013</xref>; <xref rid="B106" ref-type="bibr">Maio, 2018</xref>; <xref rid="B35" ref-type="bibr">Colon et al., 2023</xref>; <xref rid="B51" ref-type="bibr">Faris, 2024</xref>).</p><p>The principle behind the use of these products is based on strengthening the ECM in the dermal layer. They are made of various low-crosslinking polymeric ingredients with different effects on the skin (<xref rid="B182" ref-type="bibr">Yi et al., 2024</xref>). Among the most used ingredients are hyaluronic acid, poly-L-lactic acid, polymethylmethacrylate, and calcium hydroxyapatite (CaHA) (<xref rid="B35" ref-type="bibr">Colon et al., 2023</xref>).</p><p>Hyaluronic acid is the most commonly used dermal filler, naturally found in the skin, being safe and effective for use (<xref rid="B182" ref-type="bibr">Yi et al., 2024</xref>). Poly-L-lactic acid is synthetic, acting as a collagen stimulator, recommended for softening lines and treating wrinkles (<xref rid="B10" ref-type="bibr">Ao et al., 2024</xref>). Similarly, according to the <xref rid="B6" ref-type="bibr">American Board of Cosmetic Surgery (2022)</xref>, polymethylmethacrylate comprises synthetic microspheres that remain under the skin indefinitely, providing continuous support and containing collagen in their composition. In addition, CaHA is a natural substance found in bones that helps stimulate the skin&#x02019;s natural collagen production and is recommended for treating deeper lines.</p><p>Focusing on hyaluronic acid fillers due to their widespread use, it is the most abundant glycosaminoglycan found in the human dermis, contributing to tissue hydration and volume, as well as providing structural support (<xref rid="B14" ref-type="bibr">Ballin et al., 2015</xref>; <xref rid="B175" ref-type="bibr">Wongprasert et al., 2022</xref>). A recent study by <xref rid="B27" ref-type="bibr">Chen et al. (2023)</xref> demonstrated the anti-aging ability of hyaluronic acid fillers by inhibiting the expression of MMP-1, promoting collagen accumulation, and increasing the expression of dermo-epidermal junction proteins.</p><p>One of the most significant advantages of hyaluronic acid fillers is that they can be easily removed by injecting hyaluronidase (<xref rid="B175" ref-type="bibr">Wongprasert et al., 2022</xref>). However, some limitations persist in their use, which can sometimes extend to other types of fillers, such as the duration of the compounds, discomfort caused by the injections, and the ability to achieve precise delivery of the fillers to the intended location and skin layer (<xref rid="B35" ref-type="bibr">Colon et al., 2023</xref>).</p><p>Growth factors are polypeptides or proteins that regulate physiological processes in and between cells. They are naturally found in the skin, secreted by various cell types in this tissue. Many growth factors are involved in wound healing, both acute and chronic, and are some of the most important signalers during this process (<xref rid="B122" ref-type="bibr">Pamela, 2018</xref>; <xref rid="B180" ref-type="bibr">Yamakawa and Hayashida, 2019</xref>; <xref rid="B167" ref-type="bibr">Vaidyanathan, 2021</xref>). Furthermore, the processes of aging and wound healing naturally stimulate the release of growth factors, which affect critical biochemical repair pathways in the dermal matrix and have inspired the use of these factors to improve skin appearance (<xref rid="B88" ref-type="bibr">Kremer and Burkemper, 2024</xref>).</p><p>Some of the growth factors used in skin treatment are EGF, FGF, hepatocyte growth factor (HGF), and IGF-1, which can be used in combination (<xref rid="B167" ref-type="bibr">Vaidyanathan, 2021</xref>; <xref rid="B180" ref-type="bibr">Yamakawa and Hayashida, 2019</xref>). They can come from various sources, including human and non-human cell cultures and recombinant sources (<xref rid="B137" ref-type="bibr">Quinlan et al., 2023</xref>).</p><p>Treatments involving the use of different growth factors have been reported to improve wrinkles, skin texture, photo-damage, and the overall appearance of facial skin (<xref rid="B137" ref-type="bibr">Quinlan et al., 2023</xref>). In addition to cosmetic use, human EGF (hEGF) is also applied in regenerative medicine for the treatment of alopecia, dermatitis following chemotherapy, burns, diabetic foot ulcers, and post-surgical ulcers (<xref rid="B87" ref-type="bibr">Kong and Hong, 2013</xref>; <xref rid="B83" ref-type="bibr">Kim et al., 2017</xref>; <xref rid="B46" ref-type="bibr">Esquirol-Caussa and Herrero-Vila, 2019</xref>; <xref rid="B73" ref-type="bibr">Jeon et al., 2019</xref>; <xref rid="B113" ref-type="bibr">Kahraman et al., 2019</xref>; <xref rid="B99" ref-type="bibr">Lou, 2021</xref>; <xref rid="B167" ref-type="bibr">Vaidyanathan, 2021</xref>).</p><p>The use of EGF for aesthetic purposes also shows broad applications, presenting a regenerative effect in the aging skin process by promoting the migration of aged fibroblasts and increasing the synthesis of hyaluronic acid and collagen in this tissue (<xref rid="B82" ref-type="bibr">Kim et al., 2015</xref>; <xref rid="B112" ref-type="bibr">Miller-Kobisher et al., 2021</xref>; <xref rid="B167" ref-type="bibr">Vaidyanathan, 2021</xref>). Growth factors can also be combined with other treatments for apparent skin rejuvenation, such as lasers, microneedling, radiofrequency, or chemical peels, to amplify results or improve side effects from these treatments (<xref rid="B137" ref-type="bibr">Quinlan et al., 2023</xref>). However, in recent years, the development of cell-penetrating peptides associated with growth factors has improved the topical application of these factors, increasing their ability to penetrate the skin and epithelial cells (<xref rid="B28" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="B33" ref-type="bibr">Choi et al., 2018</xref>; <xref rid="B73" ref-type="bibr">Jeon et al., 2019</xref>, <xref rid="B89" ref-type="bibr">Lee et al., 2020</xref>, <xref rid="B177" ref-type="bibr">Xie et al., 2020</xref>.</p><p>Aiming to correct genetic defects and thereby prevent or cure genetic disorders, gene therapy has been applied to skin regenerative medicine. All types of skin diseases are candidates for gene therapy, from inflammatory diseases to skin cancers and genodermatoses (<xref rid="B3" ref-type="bibr">Ain et al., 2021</xref>), as well as more aesthetic aspects like skin regeneration and scar and keloid treatment (<xref rid="B70" ref-type="bibr">Hosseinkhani et al., 2023</xref>; <xref rid="B103" ref-type="bibr">Luo et al., 2023</xref>).</p><p>Gene therapy technologies include the use of messenger RNA, silencing RNA, antisense oligonucleotides (AON), plasmid DNA, minicircle DNA, mini-string DNA, and CRISPR/Cas9 technology (<xref rid="B168" ref-type="bibr">Wan et al., 2021</xref>; <xref rid="B60" ref-type="bibr">Guri-Lamce et al., 2024</xref>; <xref rid="B163" ref-type="bibr">Tenchov et al., 2024</xref>), which must have specific action on the desired area of the skin, representing one of the current challenges in this type of therapy.</p><p>Currently, there are three main methods of delivering gene therapies to the skin: viral delivery, nanoparticles and physical methods. In this perspective, viral delivery is the most used and effective method (<xref rid="B129" ref-type="bibr">Pican&#x000e7;o-Castro et al., 2020</xref>), though it presents challenges such as limitations in efficacy due to pre-existing immunity, the inability to redose, and genome integration capacity, which increases the risk of unwanted insertional mutagenesis. Additionally, there are size limitations for the genetic cargo (<xref rid="B9" ref-type="bibr">Anzalone et al., 2019</xref>; <xref rid="B3" ref-type="bibr">Ain et al., 2021</xref>). Lipid-based nanoparticles, a more recent and promising method (<xref rid="B60" ref-type="bibr">Guri-Lamce et al., 2024</xref>); polymeric nanoparticles, capable of associating with negatively charged genetic cargoes and forming spherical complexes, but which still present high toxicity related to particle size (<xref rid="B20" ref-type="bibr">Blakney et al., 2020</xref>); and physical methods, such as electroporation, ultrasound application, or microneedles (<xref rid="B168" ref-type="bibr">Wan et al., 2021</xref>), which have limitations for clinical application, such as limited cargo capacity and challenges with whole-body administration (<xref rid="B3" ref-type="bibr">Ain et al., 2021</xref>).</p><p>Other substances can be incorporated into skin care products, playing an active role in tissue regeneration or inflammation by improving ECM synthesis or inhibiting its degradation, neutralizing free reactive species, or reducing proinflammatory factors (<xref rid="B107" ref-type="bibr">Makpol et al., 2013</xref>; <xref rid="B169" ref-type="bibr">Wang H. et al., 2021</xref>; <xref rid="B165" ref-type="bibr">Torres et al., 2023</xref>). Among these substances, zinc-based compounds stand out. This metal has been shown to reduce inflammation and the risk of infections, being involved in cell proliferation and migration and collagen synthesis, thus promoting epithelialization (<xref rid="B93" ref-type="bibr">Lin et al., 2017</xref>; <xref rid="B30" ref-type="bibr">Chen et al., 2022</xref>; <xref rid="B131" ref-type="bibr">Pino et al., 2023</xref>). Other substances primarily act as moisturizers, provided by ingredients that increase the synthesis of structural skin lipids, directly restoring the skin barrier, such as vitamin A, or hygroscopic substances like dexpanthenol, which bind to and retain water in the stratum corneum (<xref rid="B94" ref-type="bibr">Liu, 2022</xref>). Other substances are lipids, oils, and fatty acids, known as emollients, such as petrolatum derivatives, which also promote hydration by directly replacing missing fatty acids in the tissue (<xref rid="B44" ref-type="bibr">Elias, 2022</xref>; <xref rid="B165" ref-type="bibr">Torres et al., 2023</xref>).</p></sec><sec id="s4-3"><title>4.3 Wound dressings</title><p>Smart dressings were developed to enhance wound care management based on the injury type and patient conditions (<xref rid="B139" ref-type="bibr">Raju et al., 2022</xref>). Multifunctional wound dressings promote wound healing by encapsulating bioactive substances, sustaining the release of medicines by stimuli-responsive technology (<xref rid="B139" ref-type="bibr">Raju et al., 2022</xref>). Biopolymers such as alginate, chitosan, polyvinyl alcohol (PVA), and collagen are increasingly used to create innovative wound dressings due to their cost-effectiveness and eco-friendliness. Among these, alginate dressings are the most popular because they promote skin regeneration, accelerate wound closure, minimize scarring, absorb exudates effectively, and are biocompatible. Alginate&#x02019;s gelling properties and stability in warm environments make it ideal for various applications, including hydrogels, nanofibers, dermal patches, films, and foams (<xref rid="B117" ref-type="bibr">Nqoro et al., 2022</xref>).</p><p>Other than that, hydrocolloids are effective in wound care because they can absorb significant amounts of wound fluid and are impermeable to water vapor, creating a moist healing environment. They also block oxygen, which speeds up epithelialization and collagen synthesis while lowering the pH to reduce bacterial growth (<xref rid="B116" ref-type="bibr">Nguyen et al., 2023</xref>). Nonetheless, new smart hydrogel wound dressings with embedded sensors have been rapidly developed to monitor wound conditions. Notable examples include flexible pH-sensing alginate-based hydrogel fibers for skin wounds and PVA/xyloglucan (PVA/XG) hydrogel membranes that absorb exudate and release biological factors (<xref rid="B160" ref-type="bibr">Tamayol et al., 2016</xref>; <xref rid="B4" ref-type="bibr">Ajovalasit et al., 2018</xref>; <xref rid="B162" ref-type="bibr">Tavakoli and Klar, 2020</xref>).</p><p>Although high-end wound dressings have been developed in recent years, the products face several limitations, including a complicated production process, inadequate quality assurance for biological materials and questions about the effectiveness of their components for widespread use. In addition to that, more trials and experiments are needed to assess the true effectiveness of these advanced dressings in wound healing (<xref rid="B116" ref-type="bibr">Nguyen et al., 2023</xref>).</p></sec></sec><sec id="s5"><title>5 Skin bioengineering</title><p>Tissue engineering has become a multidisciplinary research field that involves the use of techniques to replicate biological prototypes, such as skin, to study the regeneration of physiological tissue on repairing or replacement of damaged skin (<xref rid="B17" ref-type="bibr">Berthiaume et al., 2011</xref>; <xref rid="B40" ref-type="bibr">Deepa and Bhatt, 2024</xref>; <xref rid="B172" ref-type="bibr">Wei et al., 2024</xref>). Indeed, it is possible to introduce biomaterials and hydrogels, which can be used as scaffolds to facilitate wound healing, combined with the knowledge of cell culture, for the improvement of techniques such as the use of nanomaterials and 3D bioprinting (<xref rid="B86" ref-type="bibr">Kondej et al., 2024</xref>; <xref rid="B172" ref-type="bibr">Wei et al., 2024</xref>; <xref rid="B100" ref-type="bibr">Loukelis et al., 2024</xref>; <xref rid="B18" ref-type="bibr">Bian et al., 2024</xref>).</p><sec id="s5-1"><title>5.1 Organotypic cultures &#x02013; 3D <italic>in vitro</italic> skin</title><p>Studies in the last 20&#x000a0;years have involved the use of different skin cell cultures (mainly keratinocytes), umbilical cord mesenchymal stem cells differentiated to keratinocytes, or co-culture of skin cells with other cell types, including immune cells and dermal fibroblasts, in a two-dimensional (2D) monolayer (<xref rid="B1" ref-type="bibr">Abaci et al., 2017</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>), to study the signaling pathways of skin diseases such as psoriasis or melanoma, wound healing, also to test the efficacy of safety treatments (<xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>). However, 2D models do not often represent a sufficient level of complexity to assess the various cell-cell and cell-extracellular matrix interactions, as well as oxygen and nutrient gradients (<xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>).</p><p>On the other hand, it is possible to better understand most complex skin diseases in the three-dimensional (3D) microenvironment by involving additional cell lineages, such as immune cells or skin appendages as innervation type, to generate more effective <italic>in vitro</italic> skin models, using spheroids or skin constructs, for example, to improve skin replacement therapy (<xref rid="B1" ref-type="bibr">Abaci et al., 2017</xref>; <xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>; <xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>).</p></sec><sec id="s5-2"><title>5.2 Spheroids</title><p>The <italic>in vivo</italic> model can be better mimicked in spheroid cultures compared to 2D models, representing a more complex tissue architecture, with increased cell-cell contacts and heterogeneous cell growth. In addition, spheroids have been used for semi-high-throughput drug screening, as well as being used in co-culture models to evaluate different tissue responses under paracrine stimulation (<xref rid="B138" ref-type="bibr">Raghavan et al., 2016</xref>; <xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>; <xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>).</p><p>The application of spheroid cultures in skin models can be generated from cell aggregates of fibroblast or keratinocyte lineages, for example, under non-adherent conditions, by so-called spinner culture, hanging drop, magnetic levitation or gel incorporation (<xref rid="B1" ref-type="bibr">Abaci et al., 2017</xref>; <xref rid="B85" ref-type="bibr">Klicks et al., 2019</xref>; <xref rid="B149" ref-type="bibr">Sch&#x000e4;fer et al., 2021</xref>; <xref rid="B119" ref-type="bibr">Ohguro et al., 2024</xref>). To improve the formation of the spheroids, it is important to choose an ECM based on biomaterials, such as hydrogels or collagens, for the architecture of the dermal matrix (<xref rid="B45" ref-type="bibr">Enyedi et al., 2023</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>).</p><p>Some methods for evaluating the different cell configurations in spheroids still remain limited, but the main ones based on microscopy, such as phase contrast microscopy, are used to analyze the size and shape of spheroids. Other methods, such as cell surface staining and flow cytometry, are used to analyze the presence of specific molecules. Cryosectioning, after fixation in formalin and embedding in paraffin, is used for a deeper view of the sectioned spheroid (<xref rid="B54" ref-type="bibr">Filipiak-Duliban et al., 2022</xref>; <xref rid="B62" ref-type="bibr">Habanjar et al., 2021</xref>; <xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>).</p><p>Due to the cell aggregate structure, spheroid nuclei are exposed to low oxygen conditions, as well as limited access to nutrients and metabolites, which can lead to an increase in apoptotic cells (<xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>; <xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>). On the other hand, the cells on the periphery are proliferative, due to the availability of oxygen and nutrients. Interestingly, the middle layer contains quiescent and senescent cells, and as a result, this spheroid configuration becomes a suitable model for testing pathophysiological conditions (<xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>; <xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>; <xref rid="B118" ref-type="bibr">Ohguro et al., 2023</xref>).</p></sec><sec id="s5-3"><title>5.3 Skin reconstructs</title><p>Another model of organotypic cultures are the so-called &#x0201c;raft&#x0201d; cultures, also known as skin reconstructs. Cells are established in a manner as to allow the stratified epithelium and the dermal component of the skin, to be reconstituted in a tissue culture environment. Keratinocytes, for example, are seeded in a dermal equivalent containing fibroblast and, when raised to the air-liquid interface, reproduce the process of stratification and terminal differentiation of keratinocyte (<xref rid="B85" ref-type="bibr">Klicks et al., 2019</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>). Histological analysis of these skin reconstructs shows the similarity and tissue organization to human skin, with a cornified epidermal-equivalent appearing on top of a dermal, containing human fibroblasts (<xref rid="B85" ref-type="bibr">Klicks et al., 2019</xref>; <xref rid="B97" ref-type="bibr">Loke et al., 2021</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>).</p><p>This skin reconstruct is a useful system for testing pharmacological dynamics, efficacy tests, analysis of absorption by different forms of administration, or for preclinical screening of drugs and cosmetics (<xref rid="B164" ref-type="bibr">Torre et al., 2020</xref>; <xref rid="B134" ref-type="bibr">Portugal-Cohen et al., 2023</xref>; <xref rid="B159" ref-type="bibr">Suthar et al., 2024</xref>). This model takes less time to obtain results and is less expensive than performing experiments using animals (<xref rid="B1" ref-type="bibr">Abaci et al., 2017</xref>; <xref rid="B79" ref-type="bibr">Karras and Kunz, 2024</xref>). Therefore, it has been emphasized in recent years that organotypic cultures for skin reconstructions can also be obtained using the bioprinting technique, in order to construct highly reproducible dermal equivalents, with architecture similar to the <italic>in vivo</italic> (<xref rid="B37" ref-type="bibr">Cubo et al., 2016</xref>; <xref rid="B53" ref-type="bibr">Fernandes et al., 2022</xref>; <xref rid="B18" ref-type="bibr">Bian et al., 2024</xref>), to be widely used in regenerative medicine or in strategies for testing immunotherapy (<xref rid="B11" ref-type="bibr">Ao et al., 2022</xref>; <xref rid="B148" ref-type="bibr">Santos et al., 2023</xref>).</p></sec><sec id="s5-4"><title>5.4 Bioprinting</title><p>Tissue bioengineering has been expanding as a new strategy by employing advanced techniques of bioprinting, biopolymer engineering, stem cell research and nanomedicine (<xref rid="B13" ref-type="bibr">Augustine, 2018</xref>; <xref rid="B126" ref-type="bibr">Pasierb et al., 2022</xref>; <xref rid="B172" ref-type="bibr">Wei et al., 2024</xref>). Bioprinting has attracted attention as a promising technique, in which the technology aims to generate, precisely, a controlled and organized complex with similar architectures of native tissues (<xref rid="B100" ref-type="bibr">Loukelis et al., 2024</xref>; <xref rid="B18" ref-type="bibr">Bian et al., 2024</xref>). Bioprinting has been used to generate tissues and transplants, including skin and its multilayers, tracheal splints, cardiac tissue and cartilaginous textures (<xref rid="B80" ref-type="bibr">Kaur et al., 2019</xref>; <xref rid="B111" ref-type="bibr">Miguel et al., 2019</xref>; <xref rid="B18" ref-type="bibr">Bian et al., 2024</xref>).</p><p>In fact, bioprinting technique has the potential to revolutionize contemporary regenerative medicine, considering that by taking advantage of tissue regeneration techniques. Using approaches that facilitates the production of skin and consequently its use in cases of wound closure, it is also possible within this model to mimic characteristic inflammatory profiles, in order to study drug-related toxicity or investigate the pathological mechanism of some skin diseases, including psoriasis and atopic dermatitis (<xref rid="B141" ref-type="bibr">Randall et al., 2018</xref>; <xref rid="B98" ref-type="bibr">Lorthois et al., 2019</xref>; <xref rid="B41" ref-type="bibr">Derr et al., 2019</xref>; <xref rid="B96" ref-type="bibr">Liu et al., 2020</xref>; <xref rid="B40" ref-type="bibr">Deepa and Bhatt, 2024</xref>).</p><p>The simultaneous incorporation of different cells into the bioprint, including fibroblasts and melanocytes in dermal equivalents, makes it possible to study the impact of UV radiation (<xref rid="B126" ref-type="bibr">Pasierb et al., 2022</xref>). Compared to machining prototypes, bioprinting makes skin production cheaper and faster, as the prototype can be finished in hours, allowing the process to be efficient, even with design modifications in production. The manufacturing process can also reduce material costs, as it uses only the amount of material needed for the prototype itself, minimizing or eliminating waste (<xref rid="B169" ref-type="bibr">Wang H. et al., 2021</xref>; <xref rid="B171" ref-type="bibr">Wang Z. et al., 2021</xref>).</p><p>Other advantages of using the bioprinting technique include: 1) customization of the skin to be used. Depending on the shape and depth of the wound surface, imaging technology using computer digitization can quickly print the skin graft compatible with the wound. Indeed, this technique confers the characteristics of punctuality, high flow and high repeatability (<xref rid="B173" ref-type="bibr">Weng et al., 2021</xref>). 2) the use of bioinks, which can be deposited flexibly and precisely with different biological agents, including living cells, nucleic acids, growth factors, among others, is usually required to help build skin structures (<xref rid="B191" ref-type="bibr">Zhu et al., 2016</xref>; <xref rid="B172" ref-type="bibr">Wei et al., 2024</xref>; <xref rid="B100" ref-type="bibr">Loukelis et al., 2024</xref>). According to the different printing materials, three different techniques of bioprinting can be mentioned, such as: droplet-based bioprinting (DBB), laser-assisted bioprinting (LAB) and extrusion-based bioprinting (EBB) (<xref rid="B59" ref-type="bibr">Gudapati et al., 2016</xref>; <xref rid="B173" ref-type="bibr">Weng et al., 2021</xref>; <xref rid="B76" ref-type="bibr">Kang et al., 2022</xref>).</p></sec><sec id="s5-5"><title>5.5 Droplet based bioprinting (DBB)</title><p>DBB technique includes the drop-by-drop mode. In this model, drops of biomaterial on a substrate are deposited when necessary. DBB-based bioprinters are suitable for deposition and patterning of materials, due to their high precision and minimal biomaterial waste. In addition, DBB mainly uses piezoelectric, thermal or electrostatic forces to generate droplets, which can precisely deposit the biomaterial to make a spatially heterogeneous tissue structure (<xref rid="B59" ref-type="bibr">Gudapati et al., 2016</xref>; <xref rid="B109" ref-type="bibr">Matai et al., 2020</xref>; <xref rid="B76" ref-type="bibr">Kang et al., 2022</xref>). Its non-contact printing mode is more suitable for biological printing directly onto a wound, for example,. Some studies have used the DBB technique to print human keratinocytes and fibroblasts directly onto dermal wounds on the backs of mice. Compared to the control group without any biological dressing, the skin grafts in the experimental group promoted wound healing (<xref rid="B59" ref-type="bibr">Gudapati et al., 2016</xref>; <xref rid="B109" ref-type="bibr">Matai et al., 2020</xref>; <xref rid="B171" ref-type="bibr">Wang Z. et al., 2021</xref>). On the other hand, DBB has some limitations. Its inkjet injector is small, measuring up to 150&#x000a0;&#x003bc;m, which can be easily blocked by biomaterials. Only low-viscosity hydrogels or other low-concentration biological agents can be used (<xref rid="B169" ref-type="bibr">Wang H. et al., 2021</xref>).</p></sec><sec id="s5-6"><title>5.6 Laser-assisted bioprinting (LAB)</title><p>LAB technique consists of the emission of laser light, that is focused on the metal film on the back of the silicate glass and heated locally, so that the bioink deposited on the equipment evaporates and is sprayed onto the substrate in the form of liquid drops (<xref rid="B109" ref-type="bibr">Matai et al., 2020</xref>; <xref rid="B171" ref-type="bibr">Wang Z. et al., 2021</xref>). The LAB technique mainly uses a nanosecond laser with ultraviolet wavelengths as an energy source, and its printing resolution can reach the picogram level, performing bioprinting without direct contact with the substrate and can print cells with high resolution. (<xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>). However, LAB does not have a suitable rapid gelling mechanism yet, which limits its ability to produce high-performance prints (<xref rid="B169" ref-type="bibr">Wang H. et al., 2021</xref>; <xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>).</p></sec><sec id="s5-7"><title>5.7 Extrusion-based bioprinting (EBB)</title><p>EBB technique makes controllable impressions using fluid distribution systems and automated machines. Under the control of a computer, the biomaterial passes through a catheter, using pneumatic, piston or screw approaches (<xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>). Hydrogels better perform in bioprinting by pneumatic extrusion, because it is kept in this material the profile of printed filaments, after extrusion. The screw-driven structure can bioprint biomaterial at high viscosity, which is conducive to producing a more stable bioprinted tissue (<xref rid="B192" ref-type="bibr">Zieli&#x00144;ski et al., 2023</xref>). In addition, extrusion bioprinting can print a porous grid structure, promote the circulation of nutrients and metabolites, which allows better control over porosity, shape and distribution of cells in the printed prototype (<xref rid="B126" ref-type="bibr">Pasierb et al., 2022</xref>; <xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>). Compared to DBB and LAB models, the advantages of EBB include faster bioprinting speed, more usable bioink types (including cell clusters, high-viscosity hydrogels, microcarriers and cell matrix components) (<xref rid="B126" ref-type="bibr">Pasierb et al., 2022</xref>; <xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>), more versatility and suitability for manufacturing prosthetic implants for tissue bioengineering. However, the limitation of this technique is that it has a lower resolution of at least 100&#x000a0;&#x000b5;m (<xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>; <xref rid="B192" ref-type="bibr">Zieli&#x00144;ski et al., 2023</xref>).</p><p>In general, different approaches in bioprinting techniques are used, in order to allow specialists to acquire more precision and high resolution in the regeneration of the skin and its appendages, including hair follicles, sebaceous and sweat glands. The same approaches might be used on selecting between the different biomaterials, which make the skin cell lineages remain highly viable and metabolically active, to keep the accuracy in replicating the tissue layers and to not compromise functionality (<xref rid="B173" ref-type="bibr">Weng et al., 2021</xref>).</p></sec><sec id="s5-8"><title>5.8 Biomaterials</title><p>Biomaterials can be of natural, synthetic, or a combination of both origins and are of great interest in tissue engineering due to their properties of biocompatibility, biodegradability, promoting cell adhesion and migration in scaffolds, potential resemblance the extracellular matrix, and presenting controllable properties and architecture (<xref rid="B26" ref-type="bibr">Chaudhari et al., 2016</xref>; <xref rid="B95" ref-type="bibr">Liu et al., 2023</xref>).</p><p>Natural biomaterials are primarily derived from proteins, such as collagen and spider silk, for example, (<xref rid="B95" ref-type="bibr">Liu et al., 2023</xref>), but can also originate from carbohydrates, such as alginate (<xref rid="B52" ref-type="bibr">Farshidfar et al., 2023</xref>).</p><p>Firstly, collagen is a protein that contains triple helices capable of forming strong and stable fibers through cross-linking. This stability can be used to form scaffolds that resemble the ECM of living tissues (<xref rid="B25" ref-type="bibr">Chattopadhyay and Raines, 2014</xref>; <xref rid="B7" ref-type="bibr">Amirrah et al., 2022</xref>; <xref rid="B190" ref-type="bibr">Zhu et al., 2022</xref>). Thus, in regenerative medicine, collagen as a biomaterial can be used as a wound dressing, promoting healing, or as a supplement for the skin, improving aspects such as elasticity and hydration (<xref rid="B57" ref-type="bibr">Ghomi et al., 2021</xref>).</p><p>Spider silk, as a natural biomaterial, is explored for its biocompatibility and low density. Because it is difficult to cultivate directly from arachnids, this protein has been produced recombinantly for the construction of scaffolds for cell culture. Using these supports, the regeneration of bone, cartilage, muscle, nerve, and epidermal tissues, especially in burn patients, has been studied. (<xref rid="B145" ref-type="bibr">Salehi et al., 2020</xref>).</p><p>It is important to highlight that some materials have limited properties, such as alginate, which has low stability due to its chemical properties, and polydopamine, which has low hydrogel-forming capacity. However, they can be used in combination with other materials, such as hydroxyapatite, chitosan, gelatin, and collagen, to achieve results and applications in tissue engineering. Thus, in combination, they can be used for bone tissue repair, corneal reconstruction, wound healing and covering, and even in drug delivery systems (<xref rid="B52" ref-type="bibr">Farshidfar et al., 2023</xref>; <xref rid="B181" ref-type="bibr">Yazdi et al., 2022</xref>).</p><p>Another way to apply the biomaterials, in general, is using as hydrogels, which provide a moist environment with the ability to retain proteins, growth factors, and nutrients within the gel structure and release these molecules into the medium (<xref rid="B17" ref-type="bibr">Berthiaume et al., 2011</xref>; <xref rid="B90" ref-type="bibr">Lei et al., 2022</xref>). Due to technological advancements in tissue engineering, it has become possible to work on an increasingly smaller scale of these gels, creating nanogels which can reach smaller and more internal wounds than hydrogels, ensuring drug release in the region, facilitating wound healing and tissue regeneration (<xref rid="B58" ref-type="bibr">Grimaudo et al., 2019</xref>; <xref rid="B22" ref-type="bibr">Brianna et al., 2024</xref>). In addition to hydrogels, there are also nanomaterials, which can be made of a single chemical element, such as silver or gold, that possess antimicrobial characteristics, can stimulate cell growth and can be delivered in systems along with nanogels (<xref rid="B16" ref-type="bibr">Bellu et al., 2021</xref>). The field of nanostructures in regenerative medicine and tissue engineering is still a novelty and shows extreme promise with ongoing research advancements.</p></sec></sec><sec id="s6"><title>6 Limitations of regenerative medicine for skin</title><p>As mentioned previously, the field of regenerative medicine for skin regeneration and rejuvenation, while promising, faces several significant limitations as described:<list list-type="simple"><list-item><p>1. High costs and limited accessibility:many regenerative therapies, especially those involving stem cells or bioengineered tissues, are expensive and require specialized equipment and expertise, limiting their accessibility to many patients.</p></list-item><list-item><p>2. Variability in treatment outcomes: the effectiveness of regenerative therapies can vary significantly depending on factors like disease severity, individual genetic background, and overall health. This makes it challenging to predict outcomes and standardize treatment protocols.</p></list-item><list-item><p>3. Long development times and regulatory hurdles: developing and gaining regulatory approval for new regenerative therapies is time-consuming and costly, which slows down the introduction of promising treatments to the market.</p></list-item><list-item><p>4. Technical challenges in production and application: producing sufficient quantities of high-quality regenerative materials (stem cells, bioengineered tissues, exosomes) consistently and reliably for clinical applications remains a significant technological hurdle. The delivery and distribution of these materials in the body can also be complex and may not always be effective.</p></list-item><list-item><p>5. Uncertain long-term efficacy and safety: while many therapies show promise in short-term studies, the long-term efficacy and safety of regenerative treatments are often not fully established. Potential risks such as tumorigenicity or immune responses need further investigation.</p></list-item><list-item><p>6. Ethical considerations: the use of stem cells and gene editing technologies raises ethical concerns, including issues related to stem cell sources (embryonic vs. adult), the potential for off-target effects in gene editing, and the ethical considerations surrounding the use of human tissue and data. Animal testing used in preclinical research may also raise ethical questions.</p></list-item><list-item><p>7. Standardization and quality control: there is a lack of standardization in the preparation and quality control of several regenerative materials and treatments (e.g., PRP, exosomes). This affects the reproducibility and reliability of treatment outcomes.</p></list-item><list-item><p>8. Complex biological systems: the skin is a complex organ with multiple interacting cell types and signaling pathways. Fully understanding these complexities is crucial for developing truly effective regenerative therapies. Current therapies often target only a subset of these mechanisms, limiting their overall impact.</p></list-item><list-item><p>9. Limited understanding of underlying mechanisms: while many regenerative therapies show promise, a complete understanding of their precise mechanisms of action is often lacking. This limits the ability to further improve and refine treatments.</p></list-item></list>
</p><p>
<xref rid="T1" ref-type="table">Table 1</xref> summarizes various techniques and approaches used in skin regeneration and treatment, categorized into <italic>in vitro</italic> and <italic>in vivo</italic> methods, as well as clinical applications. For each technique, it details specific findings, strengths, and limitations or challenges encountered. The <italic>in vitro</italic> methods include organotypic cultures (2D and 3D), spheroids, skin reconstructs, cell cultures, exosome studies, and ADSC injections. <italic>In vivo</italic> techniques cover PRP injections, growth factor application, exosome application, bioprinting, animal models, stem cell and gene therapy. Finally, clinical applications include PRP therapy, growth factor therapy, and dermal fillers. The table provides a comprehensive overview of the current state of skin regeneration research and its therapeutic potential, highlighting both the advantages and drawbacks of different methodologies.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p>
<italic>In vitro, in vivo</italic> and clinical approaches to skin repair: strengths, limitations, and specific findings.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Type</th><th align="center" rowspan="1" colspan="1">Technique/Approach</th><th align="center" rowspan="1" colspan="1">Specific findings</th><th align="center" rowspan="1" colspan="1">Strengths</th><th align="center" rowspan="1" colspan="1">Limitations/Challenges</th></tr></thead><tbody valign="top"><tr><td rowspan="5" align="center" colspan="1">
<italic>In vitro</italic>
</td><td align="left" rowspan="1" colspan="1">Organotypic cultures (2D and 3D)</td><td align="left" rowspan="1" colspan="1">Studied signaling pathways, skin disease models (psoriasis, melanoma), and wound healing; 3D models offer greater complexity than 2D</td><td align="left" rowspan="1" colspan="1">Allows for controlled conditions and high-throughput screening; 3D models better mimic <italic>in vivo</italic> conditions</td><td align="left" rowspan="1" colspan="1">2D models lack complexity; 3D models have challenges in nutrient/oxygen delivery, leading to cell death in the core</td></tr><tr><td align="left" rowspan="1" colspan="1">Spheroids</td><td align="left" rowspan="1" colspan="1">Used for semi-high-throughput drug screening and co-culture models; increased cell-cell contact and heterogeneous growth</td><td align="left" rowspan="1" colspan="1">Better mimicry of <italic>in vivo</italic> conditions than 2D</td><td align="left" rowspan="1" colspan="1">Limited access to nutrients and oxygen in the core of spheroids can affect results</td></tr><tr><td align="left" rowspan="1" colspan="1">Skin reconstructs</td><td align="left" rowspan="1" colspan="1">Mimic stratified epithelium and dermal components; Useful for testing pharmacodynamics, efficacy, and absorption</td><td align="left" rowspan="1" colspan="1">Closer to <italic>in vivo</italic> conditions; Less time and cost than animal models</td><td align="left" rowspan="1" colspan="1">Not perfectly representative of all <italic>in vivo</italic> complexities</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell cultures (various types)</td><td align="left" rowspan="1" colspan="1">Examined differentiation potential, anti-inflammatory properties, and paracrine effects of various stem cells (MSCs, ADSCs, UCMSCs, iPSCs)</td><td align="left" rowspan="1" colspan="1">Understanding fundamental cellular mechanisms</td><td align="left" rowspan="1" colspan="1">Not directly translatable to <italic>in vivo</italic> outcomes</td></tr><tr><td align="left" rowspan="1" colspan="1">Exosome studies</td><td align="left" rowspan="1" colspan="1">Investigated exosomes role in cell communication, wound healing, and skin rejuvenation; assessed effects of exosomes from various sources (ADSCs, HDFs, bovine milk)</td><td align="left" rowspan="1" colspan="1">Understanding mechanisms of exosome action</td><td align="left" rowspan="1" colspan="1">Challenges in isolation, standardization, and ensuring purity and long-term stability</td></tr><tr><td rowspan="6" align="center" colspan="1">
<italic>In vivo</italic>
</td><td align="left" rowspan="1" colspan="1">ADSCs injection</td><td align="left" rowspan="1" colspan="1">ADSCs injection into patients with alopecia areata showed improved hair growth; ADSCs reversed the aging phenotype in a mouse model</td><td align="left" rowspan="1" colspan="1">Demonstrates potential therapeutic efficacy</td><td align="left" rowspan="1" colspan="1">Limited human studies. Translation to human applications needs more research</td></tr><tr><td align="left" rowspan="1" colspan="1">PRP injections</td><td align="left" rowspan="1" colspan="1">PRP injections enhanced healing in chronic skin conditions</td><td align="left" rowspan="1" colspan="1">Demonstrates potential therapeutic efficacy</td><td align="left" rowspan="1" colspan="1">Variable results depending on preparation methods; need for standardized procedures</td></tr><tr><td align="left" rowspan="1" colspan="1">Growth factor application</td><td align="left" rowspan="1" colspan="1">Topical application improved wrinkles, skin texture, and photodamage; treatment of various skin conditions (alopecia, burns)</td><td align="left" rowspan="1" colspan="1">Demonstrates therapeutic potential</td><td align="left" rowspan="1" colspan="1">Effects can be localized and short-lived; may need combined therapies</td></tr><tr><td align="left" rowspan="1" colspan="1">Exosome application</td><td align="left" rowspan="1" colspan="1">Topical or injected exosomes improved skin health and reduced symptoms in vitiligo and other skin conditions</td><td align="left" rowspan="1" colspan="1">Demonstrates therapeutic potential</td><td align="left" rowspan="1" colspan="1">Challenges in delivery and distribution</td></tr><tr><td align="left" rowspan="1" colspan="1">Bioprinting</td><td align="left" rowspan="1" colspan="1">Generated skin tissues and transplants</td><td align="left" rowspan="1" colspan="1">Potential for creating personalized treatments</td><td align="left" rowspan="1" colspan="1">Challenges in precision, cell viability, and cost</td></tr><tr><td align="left" rowspan="1" colspan="1">Animal models (various)</td><td align="left" rowspan="1" colspan="1">Used to test various approaches (stem cell therapy, exosomes, biomaterials)</td><td align="left" rowspan="1" colspan="1">Provides relevant data for assessing safety and efficacy</td><td align="left" rowspan="1" colspan="1">Results may not directly translate to human outcomes</td></tr><tr><td rowspan="5" align="center" colspan="1">Clinical</td><td align="left" rowspan="1" colspan="1">Stem cell therapy</td><td align="left" rowspan="1" colspan="1">Treated patients with severe generalized recessive dystrophic epidermolysis bullosa, alopecia areata, and other conditions</td><td align="left" rowspan="1" colspan="1">Demonstrates therapeutic efficacy in some cases</td><td align="left" rowspan="1" colspan="1">Limited number of patients; varying results; high costs</td></tr><tr><td align="left" rowspan="1" colspan="1">PRP therapy</td><td align="left" rowspan="1" colspan="1">Used to enhance healing in chronic wounds</td><td align="left" rowspan="1" colspan="1">Demonstrates clinical efficacy</td><td align="left" rowspan="1" colspan="1">Variable results depending on preparation methods</td></tr><tr><td align="left" rowspan="1" colspan="1">Growth factor therapy</td><td align="left" rowspan="1" colspan="1">Used in combination with other therapies to treat alopecia, burns, and other conditions</td><td align="left" rowspan="1" colspan="1">Demonstrates clinical efficacy</td><td align="left" rowspan="1" colspan="1">Need for optimization and standardized procedures</td></tr><tr><td align="left" rowspan="1" colspan="1">Gene therapy (limited)</td><td align="left" rowspan="1" colspan="1">Gene therapy (CRISPR) shows promise for genetic skin disorders</td><td align="left" rowspan="1" colspan="1">Potential for long-term solutions</td><td align="left" rowspan="1" colspan="1">Ethical concerns; potential off-target effects; regulatory challenges</td></tr><tr><td align="left" rowspan="1" colspan="1">Dermal fillers</td><td align="left" rowspan="1" colspan="1">Used to treat wrinkles and other cosmetic concerns</td><td align="left" rowspan="1" colspan="1">Widely used and generally considered safe</td><td align="left" rowspan="1" colspan="1">Limited duration of effects, discomfort during injections, challenges in precise delivery</td></tr></tbody></table></table-wrap><p>
<xref rid="T2" ref-type="table">Table 2</xref> was designed in order to compare various techniques used in skin regeneration, categorized into cell-based and cell-free methods, providing a concise overview of advantages and disadvantages. The cell-based methods include cell therapy, platelet-rich plasma, and growth factors and cytokines, while the cell-free methods encompass exosomes, wound dressings, and gene therapy. Additionally, there is a section for bioengineered skin including biomaterials and nanodevices.</p><table-wrap position="float" id="T2"><label>TABLE 2</label><caption><p>Comparison of cell-based and cell-free approaches for skin regeneration.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Technique</th><th align="center" rowspan="1" colspan="1">Advantages</th><th align="center" rowspan="1" colspan="1">Disadvantages/Limitations</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="center" colspan="1">Cell-based</td><td align="center" rowspan="1" colspan="1">Cell therapy</td><td align="left" rowspan="1" colspan="1">Differentiation potential, stimulates angiogenesis, releases growth factors, and provides immunomodulation</td><td align="left" rowspan="1" colspan="1">High cost, potential immune rejection, and decreased viability with aging</td><td align="center" rowspan="1" colspan="1">
<xref rid="B75" ref-type="bibr">Jo et al. (2021)</xref>
<break/>
<xref rid="B102" ref-type="bibr">Lukomskyj et al. (2022)</xref>
<break/>
<xref rid="B176" ref-type="bibr">Wu et al. (2024)</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Platelet-rich plasma</td><td align="left" rowspan="1" colspan="1">Cost-effective, promotes wound healing via growth factors, easily prepared, and safe with minimal side effects</td><td align="left" rowspan="1" colspan="1">Variable results, lack of standardization, and requires further research to optimize application in specific conditions</td><td align="center" rowspan="1" colspan="1">
<xref rid="B177" ref-type="bibr">Xu et al., 2020</xref>
<break/>
<xref rid="B24" ref-type="bibr">Cecerska-Heryc et al. (2022)</xref>
<break/>
<xref rid="B48" ref-type="bibr">Everts et al. (2024)</xref>
</td></tr><tr><td rowspan="4" align="center" colspan="1">Cell-free</td><td align="center" rowspan="1" colspan="1">Growth factors and cytokines</td><td align="left" rowspan="1" colspan="1">Accelerates wound healing (EGF and FGF), enhances collagen production (TGF-&#x003b2;), angiogenesis (VEGF), antiinflammatory effects (IL-10), potential for scar reduction</td><td align="left" rowspan="1" colspan="1">Cost and availability, short halflife, risk of overstimulation, inflammation and immune response, tumorigenic potential, unpredictable Response</td><td align="center" rowspan="1" colspan="1">
<xref rid="B108" ref-type="bibr">Mao and Mooney (2015)</xref>
<break/>
<xref rid="B147" ref-type="bibr">Sampogna et al. (2015)</xref>
<break/>
<xref rid="B99" ref-type="bibr">Lou (2021)</xref>
<break/>
<xref rid="B35" ref-type="bibr">Colon et al., 2023</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Exosomes</td><td align="left" rowspan="1" colspan="1">Non-immunogenic, accelerates healing, promotes collagen synthesis, and poses a lower risk of immune rejection or tumorigenicity</td><td align="left" rowspan="1" colspan="1">Difficult isolation and standardization; challenges in ensuring purity and long-term stability</td><td align="center" rowspan="1" colspan="1">
<xref rid="B170" ref-type="bibr">Wang et al. (2019)</xref>
<break/>
<xref rid="B174" ref-type="bibr">Wong et al., 2020</xref>
<xref rid="B189" ref-type="bibr">Zhou et al., 2023</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Wound dressings</td><td align="left" rowspan="1" colspan="1">Provides a moist environment for healing, can be infused with bioactive compounds like growth factors, and reduces pain and healing time</td><td align="left" rowspan="1" colspan="1">High production costs, complex manufacturing, and limited large scale clinical validation</td><td align="center" rowspan="1" colspan="1">
<xref rid="B55" ref-type="bibr">Frykberg and Banks (2015)</xref>
<break/>
<xref rid="B31" ref-type="bibr">Chiu et al. (2023)</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Gene therapy (CRISPR, viral delivery)</td><td align="left" rowspan="1" colspan="1">Targets specific genetic mutations, promising for diseases like epidermolysis bullosa, can correct genetic skin conditions at the DNA level</td><td align="left" rowspan="1" colspan="1">Ethical concerns, potential off target effects, immune reactions, and regulatory challenges</td><td align="center" rowspan="1" colspan="1">
<xref rid="B2" ref-type="bibr">Abdelnour et al. (2021)</xref>
<break/>
<xref rid="B117" ref-type="bibr">Nqoro et al. (2022)</xref>
<break/>
<xref rid="B19" ref-type="bibr">Bischof et al., 2024</xref>
</td></tr><tr><td rowspan="4" align="center" colspan="1">Tissue engineering</td><td align="center" rowspan="1" colspan="1">Biomaterials (e.g., collagen, alginate)</td><td align="left" rowspan="1" colspan="1">Biocompatibility, promotes cell adhesion and migration, and mimics the extracellular matrix, useful in scaffolds and wound dressings</td><td align="left" rowspan="1" colspan="1">Some materials, like alginate, have low stability, and others, such as spider silk, are difficult to produce in large quantities</td><td align="center" rowspan="1" colspan="1">
<xref rid="B57" ref-type="bibr">Ghomi et al. (2021)</xref>
<break/>
<xref rid="B158" ref-type="bibr">Surowiecka et al. (2022)</xref>
<break/>
<xref rid="B52" ref-type="bibr">Farshidfar et al., 2023</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Nanodevices (e.g., nanofiber, hydrogels, nanocrystal and nanoparticle)</td><td align="left" rowspan="1" colspan="1">Direct stimulation of cell regrowth; Antibacterial activity; Drug delivery</td><td align="left" rowspan="1" colspan="1">It is necessary to carry out nanotoxicity testing</td><td align="center" rowspan="1" colspan="1">
<xref rid="B145" ref-type="bibr">Salehi et al., 2020</xref>; <xref rid="B16" ref-type="bibr">Bellu et al., 2021</xref>
<break/>
<xref rid="B181" ref-type="bibr">Yazdi et al. (2022)</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">Bioengineered skin</td><td align="left" rowspan="1" colspan="1">Offers improved healing and aesthetic outcomes for burns and wounds, reduces scarring, and restores functionality (e.g., elasticity, sensitivity)</td><td align="left" rowspan="1" colspan="1">High cost, immune rejection risks, and limitations in large scale production or tailored designs for individual patients</td><td align="center" rowspan="1" colspan="1">
<xref rid="B21" ref-type="bibr">Boyce and Lalley (2018)</xref>
<break/>
<xref rid="B114" ref-type="bibr">Monavarian et al. (2019)</xref>
<break/>
<xref rid="B32" ref-type="bibr">Chogan et al. (2023)</xref>
</td></tr><tr><td align="center" rowspan="1" colspan="1">3D bioprinting</td><td align="left" rowspan="1" colspan="1">Customizable, precise production of skin tissue layers, enables faster manufacturing and reduced costs, can incorporate cells like fibroblasts</td><td align="left" rowspan="1" colspan="1">Technical limitations, including low resolution and difficulty in controlling cell distribution and viability</td><td align="center" rowspan="1" colspan="1">
<xref rid="B126" ref-type="bibr">Pasierb et al., 2022</xref>
<break/>
<xref rid="B169" ref-type="bibr">Wang et al., 2021a</xref>
<break/>
<xref rid="B186" ref-type="bibr">Zhang et al., 2023</xref>
<break/>
<xref rid="B192" ref-type="bibr">Zieli&#x00144;ski et al. (2023)</xref>
</td></tr></tbody></table></table-wrap><p>Basically, cell-based therapies rely on the biological activity of living cells (e.g., growth factors, immunomodulation), while cell-free methods utilize components derived from cells or synthetic materials to stimulate tissue repair. In general, cell-based therapies offer potential for multifaceted benefits, nevertheless they are often more complex and costly to produce than cell-free options. Also, it is possible to assume that while some cell-based therapies (like PRP) have gained clinical traction, others are still in earlier stages of development. Similarly, the table indicates cell-free options like dermal fillers are established clinically whereas gene therapy, for example, remains limited due to distinct factors such as cost, scalability, and ethical issues. In addition, the comparison sheds light on the potential safety concerns associated with each technique. While cell-based methods carry risks such as immune rejection, cell-free methods have limitations regarding long-term stability and potential off-target effects (e.g., gene therapy). This is vital for evaluating the risk-benefit profile of each approach. By highlighting the limitations of current technologies, the comparison stimulates innovation and the development of new techniques. For instance, challenges in exosome isolation and standardization may boost research into improved purification and delivery methods.</p><p>In summary, comparing cell-based and cell-free methods provides a framework for assessing the strengths and weaknesses of different regenerative approaches, contributing to decisions about research direction, clinical translation, and resource allocation within the field of skin regeneration. Addressing these limitations requires continued research, development of standardized protocols, improved manufacturing processes, robust clinical trials, and careful ethical consideration of the technologies making them more effective, affordable, and accessible.</p></sec><sec id="s7"><title>7 Perspectives and future directions</title><p>Since the cave age, man has been healing his wounds, treating burns and preventing bleeding. Nowadays, the importance of aesthetics and the growth of the geriatric population is propelling the demand for skin regeneration and rejuvenation products and services. In this context, the interest in maintaining a skin with youthful appearance, the demand for treatment of disorders/disease and superficial or full-thickness skin injuries, has led to the development of regenerative medicine-based approaches, with the aim of repair, replace, regenerate, and rejuvenate (the four &#x0201c;R&#x0201d;s) the skin. In recent years we have seen rapid growth in the field of regenerative medicine-based approaches for skin.</p><p>The global regenerative medicine market size was valued at USD 29.42 billion in 2023 and it is predicted to be worth around USD 154.05 billion by 2033 with a remarkable CAGR of 18% from 2024 to 2033. The dermatology segment was valued at USD 1.87 billion in 2023 and it is expected to reach around USD 7.66 billion by 2030 (<ext-link xlink:href="https://www.precedenceresearch.com/regenerative-medicine-market" ext-link-type="uri">https://www.precedenceresearch.com/regenerative-medicine-market</ext-link>). The global scar treatment market size was estimated at USD 24 billion in 2022 and is expected to hit around USD 64.26 billion by 2032, poised to grow at a CAGR of 10.4% during the forecast period from 2023 to 2032. The growing concerns among the population regarding their aesthetic appearances are a major factor driving the growth of the global scar treatment market. Scars due to accidents and other reasons are propelling the demand for scar treatment products and services (<ext-link xlink:href="https://www.precedenceresearch.com/scar-treatment-market" ext-link-type="uri">https://www.precedenceresearch.com/scar-treatment-market</ext-link>).</p><p>The companies focusing on research and development are expected to lead the global regenerative medicine market (<ext-link xlink:href="https://www.precedenceresearch.com/scar-treatment-market)" ext-link-type="uri">https://www.precedenceresearch.com/scar-treatment-market</ext-link>). Leading competitors contending in global regenerative medicine market are as follows: Integra LifeSciences Corporation (<ext-link xlink:href="https://www.integralife.com/" ext-link-type="uri">https://www.integralife.com/</ext-link>); Aspect Biosystems (<ext-link xlink:href="https://www.aspectbiosystems.com/" ext-link-type="uri">https://www.aspectbiosystems.com/</ext-link>); Amgen, Inc (<ext-link xlink:href="https://www.amgen.com/" ext-link-type="uri">https://www.amgen.com/</ext-link>); Medtronic plc (<ext-link xlink:href="https://www.medtronic.com/br-pt/index.html" ext-link-type="uri">https://www.medtronic.com/br-pt/index.html</ext-link>); AstraZeneca (<ext-link xlink:href="https://www.astrazeneca.com.br/" ext-link-type="uri">https://www.astrazeneca.com.br/</ext-link>); Novartis AG (<ext-link xlink:href="https://www.novartis.com/" ext-link-type="uri">https://www.novartis.com/</ext-link>); Smith &#x00026; Nephew plc (<ext-link xlink:href="https://www.smith-nephew.com/pt-br" ext-link-type="uri">https://www.smith-nephew.com/pt-br</ext-link>); MiMedx Group (<ext-link xlink:href="https://www.mimedx.com/" ext-link-type="uri">https://www.mimedx.com/</ext-link>); Shenzhen SibionoGeneTech Co., Ltd. (<ext-link xlink:href="http://www.sibiono.com/en/index.aspx" ext-link-type="uri">http://www.sibiono.com/en/index.aspx</ext-link>); Baxter (<ext-link xlink:href="https://www.baxter.com.br/pt-br" ext-link-type="uri">https://www.baxter.com.br/pt-br</ext-link>).</p><p>The innovative field of skin regeneration and rejuvenation most advances include, but are not limited to (<xref rid="B21" ref-type="bibr">Boyce and Lalley, 2018</xref>):<list list-type="simple"><list-item><p>a) complete restoration of skin anatomy and physiology, anatomic and physiologic properties that may be missing by providing restoration of skin pigmentation, epidermal appendages (hair, sebaceous and sweat glands), sensory and motor innervation, vascular plexus, and subcutaneous tissues;</p></list-item><list-item><p>b) development of gene therapies for specific applications and cost-effective therapies to patients, useful to the treatment of diseases, with focus on incidence of injuries and growth of the geriatric population;</p></list-item><list-item><p>c) automated and robotic fabrication of engineered tissues to increase efficiencies and reduce costs;</p></list-item><list-item><p>d) development of instruments and medical devices for tissue engineering and regenerative medicine, organ regeneration, and organ transplantation;</p></list-item><list-item><p>e) genetic modification of autologous cells, adoption of novel stem cells-based technologies, using umbilical cord blood stem cell (allogeneic and autologous stem cells), adult stem cells (ASC), embryonic stem cells or stem cells obtained from other species (xenogeneic cell), facing and overcoming the ethical challenges due to their source of collection;</p></list-item><list-item><p>f) quantification of wounds with non-invasive biophysical instruments;</p></list-item><list-item><p>g) development of biomaterials (natural or synthetic) or biodegradable formulations that do not affect the gene expression profile of the cells through stimulation or inhibition of cell surface receptors and control of specific intracellular pathways;</p></list-item><list-item><p>h) screening of the Skin-Regenerative Potential of Peptides (<xref rid="B5" ref-type="bibr">Alencar-Silva et al., 2024</xref>);</p></list-item><list-item><p>i) development of 3D bioprinting techniques to biofabrication of skin tissue with its appendages, is very important due to their intrinsic capacity for automation, accuracy, reproducibility, scalability, and personalization of matrices with structural complexity (<xref rid="B69" ref-type="bibr">Hosseini et al., 2022</xref>);</p></list-item><list-item><p>j) the potential use of 3-dimensional organoid or stem cell-derived organoid may deliver greater patient benefits than other regenerative medicine approaches but raises new health and ethical risks (<xref rid="B65" ref-type="bibr">Harris et al., 2022</xref>).</p></list-item></list>
</p></sec><sec id="s8"><title>8 Innovation and patents in skin regeneration and rejuvenation</title><p>A comprehensive analysis of the current landscape of patent applications within the field of regenerative medicine, with a particular emphasis on skin regeneration and rejuvenation has also been performed. A detailed examination of data obtained from a Google Patents search for the period 2022&#x02013;2024 reveals substantial ongoing innovation and a considerable level of interest in this rapidly evolving area. Using keywords &#x0201c;regenerative skin&#x0201d;, &#x0201c;regenerative medicine&#x0201d;, &#x0201c;artificial skin&#x0201d;, &#x0201c;skin rejuvenation,&#x0201d; and &#x0201c;skin regeneration&#x0201d; yielded 22541, 67589, 55411,419 and 1,681 results, respectively.</p><p>Numerous patents cover anti-aging and anti-wrinkle cosmetics, rejuvenation methods, and the use of exosomes (from various sources), proteins (recombinant and non-recombinant), plant extracts, growth factors, and stem cells. Patents also target the development of devices and instruments for skin treatment and product application aimed at promoting regeneration. Specific applications include treatments for wound healing, chronic wounds, burns, aging, and skin diseases. However, the field of skin regeneration and rejuvenation is experiencing rapid growth in terms of patent activity and a large number of patents, significant research gaps exist, particularly in addressing the effects of ionizing radiation, neuron injury repair, and the development of functional artificial blood vessels.</p><p>Specifically, <xref rid="B67" ref-type="bibr">Hinsenkamp et al. (2022)</xref> reviewed tissue engineering (TE) and regenerative medicine (RM) patents from 2010 to 2020, identifying promising areas and highlighting challenges in translating research to commercial products. While many patents exist, the path to market is complex and lengthy, with regulatory hurdles and significant financial investment required.</p><p>Several patents show promise, including1) scaffold-related inventions such as the Electrospinning Company&#x02019;s multiwell plate, facilitating 3D cell culture research, which is already commercially available; methodological patents focusing on cell isolation and bioprinting techniques; 3) compositional patents involving novel bioinks and materials for 3D bioprinting, particularly those that are already part of commercially available products.</p><p>The review emphasizes that, while many patents exist, most are still in early development stages. Only a small fraction has reached commercialization, highlighting the significant challenges in this field. The authors emphasize the lengthy timelines, regulatory complexities, and funding challenges involved in moving promising TE and RM technologies from the laboratory to the market. Further innovation and research are needed to overcome these limitations.</p></sec><sec id="s9"><title>9 Regulatory and ethical</title><p>The regenerative medicine-based therapies for different pathologies, including those of the skin, are generally considered safe, although there is still a need to overcome some limitations, especially those related to tissue origin and donor factors, discrepancies in isolation and culture procedures, risk of adverse effects, such as tumorigenicity, and some ethical regulatory restrictions (<xref rid="B151" ref-type="bibr">Shimizu et al., 2022</xref>). Safety and efficacy of skin substitutes are regulated in the USA by the US Food and Drug Administration (FDA), which released a guidance document &#x0201c;Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Minimal Manipulation and Homologous Use&#x0201d; (<ext-link xlink:href="https://www.fda.gov" ext-link-type="uri">https://www.fda.gov</ext-link>) and International Society of Stem Cell Research (ISSCR) communications (<ext-link xlink:href="https://www.isscr.org/policy" ext-link-type="uri">https://www.isscr.org/policy</ext-link>). The ASTM (American Society for Testing and Materials, <ext-link xlink:href="https://www.astm.org" ext-link-type="uri">https://www.astm.org</ext-link>) F2311-08 Standard Guide for Classification of Therapeutic Skin Substitutes (defines terminology and provides classification by clinical use for products that can be substituted for tissue grafts of human or animal tissue in medical and surgical therapies of skin lesions) and F3163-16, Standard Guide for Classification of Cellular and/or Tissue-Based Products for Skin Wounds (CTPs) (defines terminology for description of CTPs for skin wounds), are used by wound care (1) scientists when developing new technology and submit dossier to agencies such as the FDA, (2) manufacturers when producing or launching new technology, (3) researchers when designing clinical trials, and (4) professionals to guide their clinical practice (<xref rid="B43" ref-type="bibr">Drueck, 2018</xref>).</p><p>Several ethical implications related to the development from bench to bedside: (1) animal experimentation, (2) handling human tissue, (3) informed consent, (4) therapeutic potential, (5) risk and safety, (6) clinical translation, and (7) societal impact. And three themes represent ethical safeguards relevant to all developmental phases: (8) scientific integrity, (9) regulation, and (10) patient and public involvement need more ethical and social reflection (<xref rid="B77" ref-type="bibr">Kanter et al., 2023</xref>).</p></sec><sec sec-type="conclusion" id="s10"><title>10 Conclusion</title><p>Regenerative therapies hold great promise in medicine, but their effectiveness can vary significantly between individuals. Factors such as disease severity, genetic background, and overall health influence the outcomes of these treatments. Additionally, many regenerative therapies remain in experimental or early clinical stages, often making them expensive and limiting accessibility for patients. Beyond cost, there are substantial regulatory hurdles, as these treatments require thorough clinical testing and approval to ensure safety and efficacy, a process that is often lengthy and complex. Furthermore, technical challenges abound in the production and application of regenerative materials like stem cells and engineered tissues, requiring specialized expertise and equipment that not all medical centers can provide. Innovative research is focused on developing minimally invasive aesthetic treatments and advancing biological skin substitutes. These innovations aim to reduce morbidity from both acquired and congenital skin diseases, as well as replace or regenerate soft tissues lost or damaged due to aging, injuries, scars, or wrinkles. The ultimate goal is to restore a rejuvenated, natural, and aesthetically pleasing appearance to the skin. Despite the promising potential of regenerative medicine, existing regulations and guidelines are insufficient to address the associated risks. The interdisciplinary nature of this field, encompassing stem cell biology, biomaterial science, gene therapy, tissue engineering, and more, needs a thorough ethical and social reflection to ensure responsible development.</p></sec></body><back><sec sec-type="author-contributions" id="s11"><title>Author contributions</title><p>ND: Conceptualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. GR: Conceptualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. MS: Conceptualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. IC: Conceptualization, Supervision, Writing&#x02013;original draft, Writing&#x02013;review and editing. HH: Conceptualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. BF-M: Conceptualization, Writing&#x02013;original draft, Writing&#x02013;review and editing. EZ: Writing&#x02013;original draft, Writing&#x02013;review and editing. FC: Conceptualization, Supervision, Writing&#x02013;original draft, Writing&#x02013;review and editing. VN: Conceptualization, Funding acquisition, Supervision, Writing&#x02013;original draft, Writing&#x02013;review and editing.</p></sec><sec sec-type="COI-statement" id="s13"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s14"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s15"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abaci</surname><given-names>H.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Doucet</surname><given-names>Y.</given-names></name><name><surname>Jack&#x000f3;w</surname><given-names>J.</given-names></name><name><surname>Christiano</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Next generation human skin constructs as advanced tools for drug development</article-title>. <source>Exp. Biol. Med.</source>
<volume>242</volume>, <fpage>1657</fpage>&#x02013;<lpage>1668</lpage>. <pub-id pub-id-type="doi">10.1177/1535370217712690</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abdelnour</surname><given-names>S. A.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>Hassanin</surname><given-names>A. A.</given-names></name><name><surname>Zuo</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>The potential of CRISPR/Cas9 gene editing as a treatment strategy for inherited diseases</article-title>. <source>Front. Cell Dev. Biol.</source>
<volume>9</volume>, <fpage>699597</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2021.699597</pub-id>
<pub-id pub-id-type="pmid">34977000</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ain</surname><given-names>Q. U.</given-names></name><name><surname>Campos</surname><given-names>E. V. R.</given-names></name><name><surname>Huynh</surname><given-names>A.</given-names></name><name><surname>Witzigmann</surname><given-names>D.</given-names></name><name><surname>Hedtrich</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Gene delivery to the skin &#x02013; how far have we come?</article-title>
<source>Trends Biotechnol.</source>
<volume>39</volume>, <fpage>474</fpage>&#x02013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2020.07.012</pub-id>
<pub-id pub-id-type="pmid">32873394</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ajovalasit</surname><given-names>A.</given-names></name><name><surname>Sabatino</surname><given-names>M. A.</given-names></name><name><surname>Todaro</surname><given-names>S.</given-names></name><name><surname>Alessi</surname><given-names>S.</given-names></name><name><surname>Giacomazza</surname><given-names>D.</given-names></name><name><surname>Picone</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Xyloglucan-based hydrogel films for wound dressing: structure-property relationships</article-title>. <source>Carbohydr. Polym.</source>
<volume>179</volume>, <fpage>262</fpage>&#x02013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2017.09.092</pub-id>
<pub-id pub-id-type="pmid">29111050</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alencar-Silva</surname><given-names>T.</given-names></name><name><surname>D&#x000ed;az-Mart&#x000ed;n</surname><given-names>R. D.</given-names></name><name><surname>Sousa dos Santos</surname><given-names>M.</given-names></name><name><surname>Saraiva</surname><given-names>R. V. P.</given-names></name><name><surname>Leite</surname><given-names>M. L.</given-names></name><name><surname>de Oliveira Rodrigues</surname><given-names>M. T.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Screening of the skin-regenerative potential of antimicrobial peptides: clavanin A, clavanin-MO, and mastoparan-MO</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume>, <fpage>6851</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25136851</pub-id>
<pub-id pub-id-type="pmid">38999961</pub-id>
</mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<collab>American Board of Cosmetic Surgery</collab> (<year>2022</year>). <article-title>What are injectable dermal fillers?</article-title>
<source>Inject. Fill. Guide</source>. <comment>Available at: <ext-link xlink:href="www.americanboardcosmeticsurgery.org" ext-link-type="uri">www.americanboardcosmeticsurgery.org</ext-link>.</comment>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amirrah</surname><given-names>I. N.</given-names></name><name><surname>Lokanathan</surname><given-names>Y.</given-names></name><name><surname>Zulkiflee</surname><given-names>I.</given-names></name><name><surname>Wee</surname><given-names>M. F. M. R.</given-names></name><name><surname>Motta</surname><given-names>A.</given-names></name><name><surname>Fauzi</surname><given-names>M. B.</given-names></name></person-group> (<year>2022</year>). <article-title>A comprehensive review on collagen type I development of biomaterials for tissue engineering: from biosynthesis to bioscaffold</article-title>. <source>Biomedicines</source>
<volume>10</volume>, <fpage>2307</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines10092307</pub-id>
<pub-id pub-id-type="pmid">36140407</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderi</surname><given-names>R.</given-names></name><name><surname>Makdissy</surname><given-names>N.</given-names></name><name><surname>Azar</surname><given-names>A.</given-names></name><name><surname>Rizk</surname><given-names>F.</given-names></name><name><surname>Hamade</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>9</volume>, <fpage>141</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-018-0889-y</pub-id>
<pub-id pub-id-type="pmid">29764513</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anzalone</surname><given-names>A. V.</given-names></name><name><surname>Randolph</surname><given-names>P. B.</given-names></name><name><surname>Davis</surname><given-names>J. R.</given-names></name><name><surname>Sousa</surname><given-names>A. A.</given-names></name><name><surname>Koblan</surname><given-names>L. W.</given-names></name><name><surname>Levy</surname><given-names>J. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Search-and-replace genome editing without double-strand breaks or donor DNA</article-title>. <source>Nature</source>
<volume>576</volume>, <fpage>149</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1711-4</pub-id>
<pub-id pub-id-type="pmid">31634902</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ao</surname><given-names>Y. J.</given-names></name><name><surname>Yi</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>G.-H.</given-names></name></person-group> (<year>2024</year>). <article-title>Application of PLLA (Poly-L-Lactic acid) for rejuvenation and reproduction of facial cutaneous tissue in aesthetics: a review</article-title>. <source>Med. Baltim.</source>
<volume>103</volume>, <fpage>e37506</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000037506</pub-id>
</mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ao</surname><given-names>Z.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Nunez</surname><given-names>A.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Microfluidics guided by deep learning for cancer immunotherapy screening</article-title>. <source>Proc. Natl. Acad. Sci.</source>
<volume>119</volume>, <fpage>e2214569119</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2214569119</pub-id>
<pub-id pub-id-type="pmid">36343225</pub-id>
</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arabpour</surname><given-names>Z.</given-names></name><name><surname>Abedi</surname><given-names>F.</given-names></name><name><surname>Salehi</surname><given-names>M.</given-names></name><name><surname>Baharnoori</surname><given-names>S. M.</given-names></name><name><surname>Soleimani</surname><given-names>M.</given-names></name><name><surname>Djalilian</surname><given-names>A. R.</given-names></name></person-group> (<year>2024</year>). <article-title>Hydrogel-based skin regeneration</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume>, <fpage>1982</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25041982</pub-id>
<pub-id pub-id-type="pmid">38396661</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Augustine</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Skin bioprinting: a novel approach for creating artificial skin from synthetic and natural building blocks</article-title>. <source>Prog. Biomater.</source>
<volume>7</volume>, <fpage>77</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1007/s40204-018-0087-0</pub-id>
<pub-id pub-id-type="pmid">29754201</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ballin</surname><given-names>A. C.</given-names></name><name><surname>Brandt</surname><given-names>F. S.</given-names></name><name><surname>Cazzaniga</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Dermal fillers: an update</article-title>. <source>Am. J. Clin. Dermatol.</source>
<volume>16</volume>, <fpage>271</fpage>&#x02013;<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s40257-015-0135-7</pub-id>
<pub-id pub-id-type="pmid">26081021</pub-id>
</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bellei</surname><given-names>B.</given-names></name><name><surname>Papaccio</surname><given-names>F.</given-names></name><name><surname>Picardo</surname><given-names>M.</given-names></name></person-group> (<year>2022</year>). <article-title>Regenerative medicine-based treatment for vitiligo: an overview</article-title>. <source>Biomedicines</source>
<volume>10</volume>, <fpage>2744</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines10112744</pub-id>
<pub-id pub-id-type="pmid">36359263</pub-id>
</mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bellu</surname><given-names>E.</given-names></name><name><surname>Medici</surname><given-names>S.</given-names></name><name><surname>Coradduzza</surname><given-names>D.</given-names></name><name><surname>Cruciani</surname><given-names>S.</given-names></name><name><surname>Amler</surname><given-names>E.</given-names></name><name><surname>Maioli</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Nanomaterials in skin regeneration and rejuvenation</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume>, <fpage>7095</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22137095</pub-id>
<pub-id pub-id-type="pmid">34209468</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berthiaume</surname><given-names>F.</given-names></name><name><surname>Maguire</surname><given-names>T. J.</given-names></name><name><surname>Yarmush</surname><given-names>M. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Tissue engineering and regenerative medicine: history, progress, and challenges</article-title>. <source>Annu. Rev. Chem. Biomol. Eng.</source>
<volume>2</volume>, <fpage>403</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-chembioeng-061010-114257</pub-id>
<pub-id pub-id-type="pmid">22432625</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bian</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><name><surname>Du</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>3D bioprinting of artificial skin substitute with improved mechanical property and regulated cell behavior through integrating patterned nanofibrous films</article-title>. <source>ACS Nano</source>
<volume>18</volume>, <fpage>18503</fpage>&#x02013;<lpage>18521</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.4c04088</pub-id>
<pub-id pub-id-type="pmid">38941540</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bischof</surname><given-names>J.</given-names></name><name><surname>Hierl</surname><given-names>M.</given-names></name><name><surname>Koller</surname><given-names>U.</given-names></name></person-group> (<year>2024</year>). <article-title>Emerging gene therapeutics for epidermolysis bullosa under development</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume>, <fpage>2243</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25042243</pub-id>
<pub-id pub-id-type="pmid">38396920</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blakney</surname><given-names>A. K.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>McKay</surname><given-names>P. F.</given-names></name><name><surname>Bouton</surname><given-names>C. R.</given-names></name><name><surname>Yeow</surname><given-names>J.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, cationic polymer</article-title>. <source>ACS Nano</source>
<volume>14</volume>, <fpage>5711</fpage>&#x02013;<lpage>5727</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c00326</pub-id>
<pub-id pub-id-type="pmid">32267667</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boyce</surname><given-names>S. T.</given-names></name><name><surname>Lalley</surname><given-names>A. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Tissue engineering of skin and regenerative medicine for wound care</article-title>. <source>Burn. Trauma 6</source>
<volume>6</volume>, <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/s41038-017-0103-y</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brianna</surname></name><name><surname>Anwar</surname><given-names>A.</given-names></name><name><surname>Teow</surname><given-names>S.-Y.</given-names></name><name><surname>Wu</surname><given-names>Y. S.</given-names></name></person-group> (<year>2024</year>). <article-title>Nanogel-based drug delivery system as a treatment modality for diverse diseases: are we there yet?</article-title>
<source>J. Drug Deliv. Sci. Technol.</source>
<volume>91</volume>, <fpage>105224</fpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2023.105224</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Callan</surname><given-names>P.</given-names></name><name><surname>Goodman</surname><given-names>G. J.</given-names></name><name><surname>Carlisle</surname><given-names>I.</given-names></name><name><surname>Liew</surname><given-names>S.</given-names></name><name><surname>Muzikants</surname><given-names>P.</given-names></name><name><surname>Scamp</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study</article-title>. <source>Clin. Cosmet. Investig. Dermatol.</source>
<volume>81</volume>, <fpage>81</fpage>. <pub-id pub-id-type="doi">10.2147/CCID.S40581</pub-id>
</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cecerska-Hery&#x00107;</surname><given-names>E.</given-names></name><name><surname>Goszka</surname><given-names>M.</given-names></name><name><surname>Serwin</surname><given-names>N.</given-names></name><name><surname>Roszak</surname><given-names>M.</given-names></name><name><surname>Grygorcewicz</surname><given-names>B.</given-names></name><name><surname>Hery&#x00107;</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Applications of the regenerative capacity of platelets in modern medicine</article-title>. <source>CytokineGrowthFactor Rev.</source>
<volume>64</volume>, <fpage>84</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2021.11.003</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>S.</given-names></name><name><surname>Raines</surname><given-names>R. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Collagen&#x02010;based biomaterials for wound healing</article-title>. <source>Biopolymers</source>
<volume>101</volume>, <fpage>821</fpage>&#x02013;<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1002/bip.22486</pub-id>
<pub-id pub-id-type="pmid">24633807</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chaudhari</surname><given-names>A.</given-names></name><name><surname>Vig</surname><given-names>K.</given-names></name><name><surname>Baganizi</surname><given-names>D.</given-names></name><name><surname>Sahu</surname><given-names>R.</given-names></name><name><surname>Dixit</surname><given-names>S.</given-names></name><name><surname>Dennis</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Future prospects for scaffolding methods and biomaterials in skin tissue engineering: a review</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>17</volume>, <fpage>1974</fpage>. <pub-id pub-id-type="doi">10.3390/ijms17121974</pub-id>
<pub-id pub-id-type="pmid">27898014</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>Skin antiaging effects of a multiple mechanisms hyaluronan complex</article-title>. <source>Ski. Res. Technol.</source>
<volume>29</volume>, <fpage>e13350</fpage>. <pub-id pub-id-type="doi">10.1111/srt.13350</pub-id>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Human epidermal growth factor coupled to different structural classes of cell penetrating peptides: a comparative study</article-title>. <source>Int. J. Biol. Macromol.</source>
<volume>105</volume>, <fpage>336</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.07.041</pub-id>
<pub-id pub-id-type="pmid">28693996</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>Z.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Application of adipose-derived stem cells in photoaging: basic science and literature review</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>11</volume>, <fpage>491</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-020-01994-z</pub-id>
<pub-id pub-id-type="pmid">33225962</pub-id>
</mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Lei</surname><given-names>D.</given-names></name><name><surname>Zheng</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Zinc-based metal organic framework with antibacterial and anti-inflammatory properties for promoting wound healing</article-title>. <source>Regen. Biomater.</source>
<volume>9</volume>, <fpage>rbac019</fpage>. <pub-id pub-id-type="doi">10.1093/rb/rbac019</pub-id>
<pub-id pub-id-type="pmid">35493287</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiu</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>D.</given-names></name><name><surname>Zhao</surname><given-names>F.</given-names></name></person-group> (<year>2023</year>). <article-title>Tissue engineering-based strategies for diabetic foot ulcer management</article-title>. <source>Adv. Wound Care</source>
<volume>12</volume>, <fpage>145</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2021.0081</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chogan</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wood</surname><given-names>F.</given-names></name><name><surname>Jeschke</surname><given-names>M. G.</given-names></name></person-group> (<year>2023</year>). <article-title>Skin tissue engineering advances in burns: a brief introduction to the past, the present, and the future potential</article-title>. <source>J. Burn Care Res.</source>
<volume>44</volume>, <fpage>S1</fpage>&#x02013;<lpage>S4</lpage>. <pub-id pub-id-type="doi">10.1093/jbcr/irac127</pub-id>
<pub-id pub-id-type="pmid">36567473</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>S. W.</given-names></name><name><surname>Pangeni</surname><given-names>R.</given-names></name><name><surname>Jung</surname><given-names>D. H.</given-names></name><name><surname>Kim</surname><given-names>S. J.</given-names></name><name><surname>Park</surname><given-names>J. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Construction and characterization of cell-penetrating peptide-fused fibroblast growth factor and vascular endothelial growth factor for an enhanced percutaneous delivery system</article-title>. <source>J. Nanosci. Nanotechnol.</source>
<volume>18</volume>, <fpage>842</fpage>&#x02013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2018.14864</pub-id>
<pub-id pub-id-type="pmid">29448503</pub-id>
</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Clayton</surname><given-names>Z. E.</given-names></name><name><surname>Tan</surname><given-names>R. P.</given-names></name><name><surname>Miravet</surname><given-names>M. M.</given-names></name><name><surname>Lennartsson</surname><given-names>K.</given-names></name><name><surname>Cooke</surname><given-names>J. P.</given-names></name><name><surname>Bursill</surname><given-names>C. A.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model</article-title>. <source>Biosci. Rep.</source>
<volume>38</volume>. <pub-id pub-id-type="doi">10.1042/BSR20180563</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Colon</surname><given-names>J.</given-names></name><name><surname>Mirkin</surname><given-names>S.</given-names></name><name><surname>Hardigan</surname><given-names>P.</given-names></name><name><surname>Elias</surname><given-names>M. J.</given-names></name><name><surname>Jacobs</surname><given-names>R. J.</given-names></name></person-group> (<year>2023</year>). <article-title>Adverse events reported from hyaluronic acid dermal filler injections to the facial region: a systematic review and meta-analysis</article-title>. <source>Cureus</source>
<volume>15</volume>, <fpage>e38286</fpage>. <pub-id pub-id-type="doi">10.7759/cureus.38286</pub-id>
<pub-id pub-id-type="pmid">37261136</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Conget</surname><given-names>P.</given-names></name><name><surname>Rodriguez</surname><given-names>F.</given-names></name><name><surname>Kramer</surname><given-names>S.</given-names></name><name><surname>Allers</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>V.</given-names></name><name><surname>Palisson</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa</article-title>. <source>Cytotherapy</source>
<volume>12</volume>, <fpage>429</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.3109/14653241003587637</pub-id>
<pub-id pub-id-type="pmid">20230217</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cubo</surname><given-names>N.</given-names></name><name><surname>Garcia</surname><given-names>M.</given-names></name><name><surname>del Ca&#x000f1;izo</surname><given-names>J. F.</given-names></name><name><surname>Velasco</surname><given-names>D.</given-names></name><name><surname>Jorcano</surname><given-names>J. L.</given-names></name></person-group> (<year>2016</year>). <article-title>3D bioprinting of functional human skin: production and <italic>in vivo</italic> analysis</article-title>. <source>Biofabrication</source>
<volume>9</volume>, <fpage>015006</fpage>. <pub-id pub-id-type="doi">10.1088/1758-5090/9/1/015006</pub-id>
<pub-id pub-id-type="pmid">27917823</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daltro</surname><given-names>S. R. T.</given-names></name><name><surname>Meira</surname><given-names>C. S.</given-names></name><name><surname>Santos</surname><given-names>I. P.</given-names></name><name><surname>Ribeiro dos Santos</surname><given-names>R.</given-names></name><name><surname>Soares</surname><given-names>M. B. P.</given-names></name></person-group> (<year>2020</year>). <article-title>Mesenchymal stem cells and atopic dermatitis: a review</article-title>. <source>Front. Cell Dev. Biol.</source>
<volume>8</volume>, <fpage>326</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00326</pub-id>
<pub-id pub-id-type="pmid">32478072</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davies</surname><given-names>C.</given-names></name><name><surname>Miron</surname><given-names>R. J.</given-names></name></person-group> (<year>2024</year>). <article-title>Autologous platelet concentrates in esthetic medicine</article-title>. <source>Periodontol</source>
<volume>2000</volume>. <pub-id pub-id-type="doi">10.1111/prd.12582</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deepa</surname><given-names>C.</given-names></name><name><surname>Bhatt</surname><given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Skin substitutes: from conventional to 3D bioprinting</article-title>. <source>J. Artif. Organs</source>. <pub-id pub-id-type="doi">10.1007/s10047-024-01481-9</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derr</surname><given-names>K.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>K.</given-names></name><name><surname>Song</surname><given-names>M. J.</given-names></name><name><surname>Sittampalam</surname><given-names>G. S.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Fully three-dimensional bioprinted skin equivalent constructs with validated morphology and barrier function</article-title>. <source>Tissue Eng. Part C Methods</source>
<volume>25</volume>, <fpage>334</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1089/ten.tec.2018.0318</pub-id>
<pub-id pub-id-type="pmid">31007132</pub-id>
</mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diotallevi</surname><given-names>F.</given-names></name><name><surname>Di Vincenzo</surname><given-names>M.</given-names></name><name><surname>Martina</surname><given-names>E.</given-names></name><name><surname>Radi</surname><given-names>G.</given-names></name><name><surname>Lariccia</surname><given-names>V.</given-names></name><name><surname>Offidani</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Mesenchymal stem cells and psoriasis: systematic review</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>23</volume>, <fpage>15080</fpage>. <pub-id pub-id-type="doi">10.3390/ijms232315080</pub-id>
<pub-id pub-id-type="pmid">36499401</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drueck</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Revise guidelines/standards to reflect clinical evidence and new technology</article-title>. <source>Adv. Wound Care</source>
<volume>7</volume>, <fpage>367</fpage>&#x02013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2018.0824</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elias</surname><given-names>P. M.</given-names></name></person-group> (<year>2022</year>). <article-title>Optimizing emollient therapy for skin barrier repair in atopic dermatitis</article-title>. <source>Ann. Allergy, Asthma Immunol.</source>
<volume>128</volume>, <fpage>505</fpage>&#x02013;<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1016/j.anai.2022.01.012</pub-id>
<pub-id pub-id-type="pmid">35065300</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Enyedi</surname><given-names>K. N.</given-names></name><name><surname>Enyedi</surname><given-names>G.</given-names></name><name><surname>Lajk&#x000f3;</surname><given-names>E.</given-names></name></person-group> (<year>2023</year>). <article-title>Three&#x02010;dimensional, PEG&#x02010;based hydrogels induce spheroid formation and enhance viability of A2058 melanoma cells</article-title>. <source>FEBS Open Bio</source>
<volume>13</volume>, <fpage>2356</fpage>&#x02013;<lpage>2366</lpage>. <pub-id pub-id-type="doi">10.1002/2211-5463.13719</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Esquirol-Caussa</surname><given-names>J.</given-names></name><name><surname>Herrero-Vila</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Human recombinant epidermal growth factor in skin lesions: 77 cases in EPItelizando project</article-title>. <source>J. Dermatol. Treat.</source>
<volume>30</volume>, <fpage>96</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1080/09546634.2018.1468546</pub-id>
</mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Everts</surname><given-names>P.</given-names></name><name><surname>Onishi</surname><given-names>K.</given-names></name><name><surname>Jayaram</surname><given-names>P.</given-names></name><name><surname>Lana</surname><given-names>J. F.</given-names></name><name><surname>Mautner</surname><given-names>K.</given-names></name></person-group> (<year>2020</year>). <article-title>Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>21</volume>, <fpage>7794</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21207794</pub-id>
<pub-id pub-id-type="pmid">33096812</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Everts</surname><given-names>P. A.</given-names></name><name><surname>Lana</surname><given-names>J. F.</given-names></name><name><surname>Alexander</surname><given-names>R. W.</given-names></name><name><surname>Dallo</surname><given-names>I.</given-names></name><name><surname>Kon</surname><given-names>E.</given-names></name><name><surname>Ambach</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Profound properties of protein-rich, platelet-rich plasma matrices as novel, multi-purpose biological platforms in tissue repair, regeneration, and wound healing</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume>, <fpage>7914</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25147914</pub-id>
<pub-id pub-id-type="pmid">39063156</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fadilah</surname><given-names>N. I.</given-names></name><name><surname>Mohd Abdul KaderJailani</surname><given-names>M. S.</given-names></name><name><surname>BadrulHisham</surname><given-names>M. A. I.</given-names></name><name><surname>SuntharRaj</surname><given-names>N.</given-names></name><name><surname>Shamsuddin</surname><given-names>S. A.</given-names></name><name><surname>Ng</surname><given-names>M. H.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Cell secretomes for wound healing and tissue regeneration: next generation acellular based tissue engineered products</article-title>. <source>J. Tissue Eng.</source>
<volume>13</volume>, <fpage>20417314221114273</fpage>. <pub-id pub-id-type="doi">10.1177/20417314221114273</pub-id>
<pub-id pub-id-type="pmid">35923177</pub-id>
</mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farabi</surname><given-names>B.</given-names></name><name><surname>Roster</surname><given-names>K.</given-names></name><name><surname>Hirani</surname><given-names>R.</given-names></name><name><surname>Tepper</surname><given-names>K.</given-names></name><name><surname>Atak</surname><given-names>M. F.</given-names></name><name><surname>Safai</surname><given-names>B.</given-names></name></person-group> (<year>2024</year>). <article-title>The efficacy of stem cells in wound healing: a systematic review</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume>, <fpage>3006</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25053006</pub-id>
<pub-id pub-id-type="pmid">38474251</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faris</surname><given-names>B. J.</given-names></name></person-group> (<year>2024</year>). <article-title>The use of facial fillers in clinical practice: the level of patient satisfaction and an overview of common clinical complications</article-title>. <source>Actas Dermosifiliogr.</source>
<volume>115</volume>, <fpage>458</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1016/j.ad.2023.10.008</pub-id>
<pub-id pub-id-type="pmid">37865230</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farshidfar</surname><given-names>N.</given-names></name><name><surname>Iravani</surname><given-names>S.</given-names></name><name><surname>&#x00026;Varma</surname><given-names>R. S.</given-names></name></person-group> (<year>2023</year>). <article-title>Alginate-based biomaterials in tissue engineering and regenerative medicine</article-title>. <source>Mar. Drugs</source>
<volume>21</volume> (<issue>3</issue>), <fpage>189</fpage>. <pub-id pub-id-type="doi">10.3390/md21030189</pub-id>
<pub-id pub-id-type="pmid">36976238</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>S.</given-names></name><name><surname>Vyas</surname><given-names>C.</given-names></name><name><surname>Lim</surname><given-names>P.</given-names></name><name><surname>Pereira</surname><given-names>R. F.</given-names></name><name><surname>Vir&#x000f3;s</surname><given-names>A.</given-names></name><name><surname>B&#x000e1;rtolo</surname><given-names>P.</given-names></name></person-group> (<year>2022</year>). <article-title>3D bioprinting: an enabling technology to understand melanoma</article-title>. <source>Cancers</source>
<volume>14</volume> (<issue>14</issue>), <fpage>3535</fpage>. <pub-id pub-id-type="doi">10.3390/cancers14143535</pub-id>
<pub-id pub-id-type="pmid">35884596</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Filipiak-Duliban</surname><given-names>A.</given-names></name><name><surname>Brodaczewska</surname><given-names>K.</given-names></name><name><surname>Majewska</surname><given-names>A.</given-names></name><name><surname>Kieda</surname><given-names>C.</given-names></name></person-group> (<year>2022</year>). <article-title>Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment</article-title>. <source>Vitro Cellular&#x00026;DevelopmentalBiology - Anim.</source>
<volume>58</volume> (<issue>5</issue>), <fpage>349</fpage>&#x02013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1007/s11626-022-00685-8</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frykberg</surname><given-names>R. G.</given-names></name><name><surname>Banks</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Challenges in the treatment of chronic wounds</article-title>. <source>Adv. Wound Care</source>
<volume>4</volume> (<issue>9</issue>), <fpage>560</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1089/wound.2015.0635</pub-id>
</mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ganceviciene</surname><given-names>R.</given-names></name><name><surname>Liakou</surname><given-names>A. I.</given-names></name><name><surname>Theodoridis</surname><given-names>A.</given-names></name><name><surname>Makrantonaki</surname><given-names>E.</given-names></name><name><surname>Zouboulis</surname><given-names>C. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Skin anti-aging strategies</article-title>. <source>Dermato-Endocrinology</source>
<volume>4</volume> (<issue>3</issue>), <fpage>308</fpage>&#x02013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.4161/derm.22804</pub-id>
<pub-id pub-id-type="pmid">23467476</pub-id>
</mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghomi</surname><given-names>E. R.</given-names></name><name><surname>Nourbakhsh</surname><given-names>N.</given-names></name><name><surname>Akbari Kenari</surname><given-names>M.</given-names></name><name><surname>Zare</surname><given-names>M.</given-names></name><name><surname>Ramakrishna</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <article-title>Collagen-based biomaterials for biomedical applications</article-title>. <source>J. Biomed. Mater. Res. Part B, Appl. Biomaterials</source>
<volume>109</volume> (<issue>12</issue>), <fpage>1986</fpage>&#x02013;<lpage>1999</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.b.34881</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grimaudo</surname><given-names>M. A.</given-names></name><name><surname>Concheiro</surname><given-names>A.</given-names></name><name><surname>Alvarez-Lorenzo</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanogels for regenerative medicine</article-title>. <source>J. Control. Release Official J. Control. Release Soc.</source>
<volume>313</volume>, <fpage>148</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2019.09.015</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gudapati</surname><given-names>H.</given-names></name><name><surname>Dey</surname><given-names>M.</given-names></name><name><surname>Ozbolat</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>A comprehensive review on droplet-based bioprinting: past, present and future</article-title>. <source>Biomaterials</source>
<volume>102</volume>, <fpage>20</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2016.06.012</pub-id>
<pub-id pub-id-type="pmid">27318933</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guri-Lamce</surname><given-names>I.</given-names></name><name><surname>AlRokh</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Maeshima</surname><given-names>R.</given-names></name><name><surname>Graham</surname><given-names>C.</given-names></name><name><surname>Hart</surname><given-names>S. L.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Topical gene editing therapeutics using lipid nanoparticles: &#x02018;gene creams&#x02019; for genetic skin diseases?</article-title>
<source>Br. J. ofDermatology</source>
<volume>190</volume> (<issue>5</issue>), <fpage>617</fpage>&#x02013;<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1093/bjd/ljad528</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gurung</surname><given-names>S.</given-names></name><name><surname>Perocheau</surname><given-names>D.</given-names></name><name><surname>Touramanidou</surname><given-names>L.</given-names></name><name><surname>Baruteau</surname><given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>The exosome journey: from biogenesis to uptake and intracellular signalling</article-title>. <source>Cell Commun. andSignaling</source>
<volume>19</volume> (<issue>1</issue>), <fpage>47</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-021-00730-1</pub-id>
</mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Habanjar</surname><given-names>O.</given-names></name><name><surname>Diab-Assaf</surname><given-names>M.</given-names></name><name><surname>Caldefie-Chezet</surname><given-names>F.</given-names></name><name><surname>&#x00026;Delort</surname><given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>3D cell culture systems: tumor application, advantages, and disadvantages</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume> (<issue>22</issue>), <fpage>12200</fpage>. <pub-id pub-id-type="doi">10.3390/ijms222212200</pub-id>
<pub-id pub-id-type="pmid">34830082</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hajialiasgary Najafabadi</surname><given-names>A.</given-names></name><name><surname>Soheilifar</surname><given-names>M. H.</given-names></name><name><surname>&#x00026;soudi-Khoram</surname><given-names>N.</given-names></name></person-group> (<year>2024</year>). <article-title>Exosomes in skin photoaging: biological functions and therapeutic opportunity</article-title>. <source>Cell Commun. Signal.</source>
<volume>22</volume> (<issue>1</issue>), <fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-023-01451-3</pub-id>
<pub-id pub-id-type="pmid">38217034</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hajimortezayi</surname><given-names>Z.</given-names></name><name><surname>Daei</surname><given-names>N.</given-names></name><name><surname>Gholizadeh</surname><given-names>N.</given-names></name><name><surname>Zakeri</surname><given-names>M.</given-names></name><name><surname>Alhili</surname><given-names>F.</given-names></name><name><surname>Hasanzadeh</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Fat transplant: amazing growth and regeneration of cells and rebirth with the miracle of fat cells</article-title>. <source>J. Cosmet. Dermatol.</source>
<volume>23</volume>, <fpage>1141</fpage>&#x02013;<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.16103</pub-id>
<pub-id pub-id-type="pmid">38010992</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>A. R.</given-names></name><name><surname>Walker</surname><given-names>M. J.</given-names></name><name><surname>Gilbert</surname><given-names>F.</given-names></name></person-group> (<year>2022</year>). <article-title>Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine</article-title>. <source>BMC Med.</source>
<volume>20</volume> (<issue>1</issue>), <fpage>499</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-022-02710-9</pub-id>
<pub-id pub-id-type="pmid">36575403</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name></person-group> (<year>2023</year>). <article-title>Research progress in skin aging, metabolism, and related products</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>24</volume> (<issue>21</issue>), <fpage>15930</fpage>. <pub-id pub-id-type="doi">10.3390/ijms242115930</pub-id>
<pub-id pub-id-type="pmid">37958920</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hinsenkamp</surname><given-names>A.</given-names></name><name><surname>Beny&#x000f3;</surname><given-names>Z.</given-names></name><name><surname>Horny&#x000e1;k</surname><given-names>I.</given-names></name></person-group> (<year>2022</year>). <article-title>Overview of tissue engineering patent strategies and patents from 2010 to 2020, including outcomes</article-title>. <source>Tissue Eng. Part B Rev.</source>
<volume>28</volume>, <fpage>626</fpage>&#x02013;<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2021.0045</pub-id>
<pub-id pub-id-type="pmid">34155925</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoang</surname><given-names>D.</given-names></name><name><surname>Pham</surname><given-names>P. T.</given-names></name><name><surname>Bach</surname><given-names>T. Q.</given-names></name><name><surname>Ngo</surname><given-names>A. T. L.</given-names></name><name><surname>Nguyen</surname><given-names>Q. T.</given-names></name><name><surname>Phan</surname><given-names>T. T. K.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Stem cell-based therapy for human diseases</article-title>. <source>SignalTransductionandTargeted Ther.</source>
<volume>7</volume> (<issue>1</issue>), <fpage>272</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-01134-4</pub-id>
</mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>M.</given-names></name><name><surname>Koehler</surname><given-names>K. R.</given-names></name><name><surname>Shafiee</surname><given-names>A.</given-names></name></person-group> (<year>2022</year>). <article-title>Biofabrication of human skin with its appendages</article-title>. <source>Adv. Healthc. Mater.</source>
<volume>11</volume> (<issue>22</issue>), <fpage>e2201626</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.202201626</pub-id>
<pub-id pub-id-type="pmid">36063498</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hosseinkhani</surname><given-names>H.</given-names></name><name><surname>Domb</surname><given-names>A. J.</given-names></name><name><surname>Sharifzadeh</surname><given-names>G.</given-names></name><name><surname>Nahum</surname><given-names>V.</given-names></name></person-group> (<year>2023</year>). <article-title>Gene therapy for regenerative medicine</article-title>. <source>Pharmaceutics</source>
<volume>15</volume> (<issue>3</issue>), <fpage>856</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics15030856</pub-id>
<pub-id pub-id-type="pmid">36986717</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huynh</surname><given-names>P. D.</given-names></name><name><surname>Tran</surname><given-names>Q. X.</given-names></name><name><surname>Nguyen</surname><given-names>S. T.</given-names></name><name><surname>Nguyen</surname><given-names>V. Q.</given-names></name><name><surname>Vu</surname><given-names>N. B.</given-names></name></person-group> (<year>2022</year>). <article-title>Mesenchymal stem cell therapy for wound healing: an update to 2022</article-title>. <source>Biomed. Res. Ther.</source>
<volume>9</volume>, <fpage>5437</fpage>&#x02013;<lpage>5449</lpage>. <pub-id pub-id-type="doi">10.15419/bmrat.v9i12.782</pub-id>
</mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jafarzadeh</surname><given-names>A.</given-names></name><name><surname>Pour Mohammad</surname><given-names>A.</given-names></name><name><surname>Keramati</surname><given-names>H.</given-names></name><name><surname>Zeinali</surname><given-names>R.</given-names></name><name><surname>Khosravi</surname><given-names>M.</given-names></name><name><surname>Goodarzi</surname><given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Regenerative medicine in the treatment of specific dermatologic disorders: a systematic review of randomized controlled clinical trials</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>15</volume>, <fpage>176</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-024-03800-6</pub-id>
<pub-id pub-id-type="pmid">38886861</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeon</surname><given-names>Y. J.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name><name><surname>Jeon</surname><given-names>Y. J.</given-names></name><name><surname>Lee</surname><given-names>W. W.</given-names></name><name><surname>Bae</surname><given-names>I. G.</given-names></name><name><surname>Yi</surname><given-names>K. W.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Increased synthesis of hyaluronic acid by enhanced penetration of CTP&#x02010;EGF recombinant in human keratinocytes</article-title>. <source>J. ofCosmeticDermatology</source>
<volume>18</volume> (<issue>5</issue>), <fpage>1539</fpage>&#x02013;<lpage>1545</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.12855</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name></person-group> (<year>2023</year>). <article-title>Application of stem cells in regeneration medicine</article-title>. <source>MedComm</source>
<volume>4</volume> (<issue>4</issue>), <fpage>e291</fpage>. <pub-id pub-id-type="doi">10.1002/mco2.291</pub-id>
<pub-id pub-id-type="pmid">37337579</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jo</surname><given-names>H.</given-names></name><name><surname>Brito</surname><given-names>S.</given-names></name><name><surname>Kwak</surname><given-names>B. M.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>M.-G.</given-names></name><name><surname>Bin</surname><given-names>B.-H.</given-names></name></person-group> (<year>2021</year>). <article-title>Applications of mesenchymal stem cells in skin regeneration and rejuvenation</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>22</volume>, <fpage>2410</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22052410</pub-id>
<pub-id pub-id-type="pmid">33673711</pub-id>
</mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kahraman</surname><given-names>M.</given-names></name><name><surname>Misir</surname><given-names>A.</given-names></name><name><surname>Kizkapan</surname><given-names>T. B.</given-names></name><name><surname>Ozcamdalli</surname><given-names>M.</given-names></name><name><surname>Uzun</surname><given-names>E.</given-names></name><name><surname>Mutlu</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>The long-term outcomes following the application of intralesional epidermal growth factor in patients with diabetic foot ulcers</article-title>. <source>J. Foot Ankle Surg.</source>
<volume>58</volume> (<issue>2</issue>), <fpage>282</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1053/j.jfas.2018.08.041</pub-id>
<pub-id pub-id-type="pmid">30612874</pub-id>
</mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kang</surname><given-names>M. S.</given-names></name><name><surname>Jang</surname><given-names>J.</given-names></name><name><surname>Jo</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>W.-H.</given-names></name><name><surname>Kim</surname><given-names>B.</given-names></name><name><surname>Chun</surname><given-names>H.-J.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Advances and innovations of 3D bioprinting skin</article-title>. <source>Biomolecules</source>
<volume>13</volume>, <fpage>55</fpage>. <pub-id pub-id-type="doi">10.3390/biom13010055</pub-id>
<pub-id pub-id-type="pmid">36671440</pub-id>
</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanter</surname><given-names>A.-F. J.</given-names></name><name><surname>Jongsma</surname><given-names>K. R.</given-names></name><name><surname>Verhaar</surname><given-names>M. C.</given-names></name><name><surname>Bredenoord</surname><given-names>A. L.</given-names></name></person-group> (<year>2023</year>). <article-title>The ethical implications of tissue engineering for regenerative purposes: a systematic review</article-title>. <source>Tissue Eng. Part B Rev.</source>
<volume>29</volume>, <fpage>167</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2022.0033</pub-id>
<pub-id pub-id-type="pmid">36112697</pub-id>
</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karimi</surname><given-names>K.</given-names></name><name><surname>Rockwell</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>The benefits of platelet-rich fibrin</article-title>. <source>Facial Plastic Surg. Clin. N. Am.</source>
<volume>27</volume> (<issue>3</issue>), <fpage>331</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsc.2019.03.005</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karras</surname><given-names>F.</given-names></name><name><surname>Kunz</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Patient-derived melanoma models</article-title>. <source>Pathology - Res. Pract.</source>
<volume>259</volume>, <fpage>155231</fpage>. <pub-id pub-id-type="doi">10.1016/j.prp.2024.155231</pub-id>
</mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaur</surname><given-names>A.</given-names></name><name><surname>Midha</surname><given-names>S.</given-names></name><name><surname>Giri</surname><given-names>S.</given-names></name><name><surname>Mohanty</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Functional skin grafts: where biomaterials meet stem cells</article-title>. <source>Stem Cells Int.</source>
<volume>2019</volume>, <fpage>1</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1155/2019/1286054</pub-id>
</mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khandpur</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Gunaabalaji</surname><given-names>D. R.</given-names></name></person-group> (<year>2021</year>). <article-title>Stem cell therapy in dermatology</article-title>. <source>Indian J. Dermatology, Venereol. Leprology</source>
<volume>87</volume>, <fpage>753</fpage>&#x02013;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.25259/IJDVL_19_20</pub-id>
</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Mun</surname><given-names>S. K.</given-names></name><name><surname>Rhee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>B. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Epidermal growth factor improves the migration and contractility of aged fibroblasts cultured on 3D collagen matrices</article-title>. <source>Int. J. Mol. Med.</source>
<volume>35</volume> (<issue>4</issue>), <fpage>1017</fpage>&#x02013;<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2015.2088</pub-id>
<pub-id pub-id-type="pmid">25647660</pub-id>
</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.-W.</given-names></name><name><surname>Kim</surname><given-names>M. G.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Koh</surname><given-names>Y.</given-names></name><name><surname>Kwon</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Topical recombinant human epidermal growth factor for oral mucositis induced by intensive chemotherapy with hematopoietic stem cell transplantation: final analysis of a randomized, double-blind, placebo-controlled, phase 2 trial</article-title>. <source>PLOS ONE</source>
<volume>12</volume> (<issue>1</issue>), <fpage>e0168854</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0168854</pub-id>
<pub-id pub-id-type="pmid">28045958</pub-id>
</mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kingsley</surname><given-names>C. S.</given-names></name></person-group> (<year>1954</year>). <article-title>Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma</article-title>. <source>Nature</source>
<volume>173</volume> (<issue>4407</issue>), <fpage>723</fpage>&#x02013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1038/173723a0</pub-id>
<pub-id pub-id-type="pmid">13165629</pub-id>
</mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klicks</surname><given-names>J.</given-names></name><name><surname>Ma&#x000df;lo</surname><given-names>C.</given-names></name><name><surname>Kluth</surname><given-names>A.</given-names></name><name><surname>Rudolf</surname><given-names>R.</given-names></name><name><surname>Hafner</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells</article-title>. <source>BMC Cancer</source>
<volume>19</volume> (<issue>1</issue>), <fpage>402</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-019-5606-4</pub-id>
<pub-id pub-id-type="pmid">31035967</pub-id>
</mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kondej</surname><given-names>K.</given-names></name><name><surname>Zawrzykraj</surname><given-names>M.</given-names></name><name><surname>Czerwiec</surname><given-names>K.</given-names></name><name><surname>Deptu&#x00142;a</surname><given-names>M.</given-names></name><name><surname>Tymi&#x00144;ska</surname><given-names>A.</given-names></name><name><surname>Piku&#x00142;a</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Bioengineering skin substitutes for wound management&#x02014;perspectives and challenges</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>25</volume> (<issue>7</issue>), <fpage>3702</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25073702</pub-id>
<pub-id pub-id-type="pmid">38612513</pub-id>
</mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kong</surname><given-names>M.</given-names></name><name><surname>Hong</surname><given-names>S. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Topical use of recombinant human epidermal growth factor (EGF)-Based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study</article-title>. <source>Asian Pac. J. Cancer Prev.</source>
<volume>14</volume> (<issue>8</issue>), <fpage>4859</fpage>&#x02013;<lpage>4864</lpage>. <pub-id pub-id-type="doi">10.7314/APJCP.2013.14.8.4859</pub-id>
<pub-id pub-id-type="pmid">24083759</pub-id>
</mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kremer</surname><given-names>M.</given-names></name><name><surname>Burkemper</surname><given-names>N.</given-names></name></person-group> (<year>2024</year>). <article-title>Aging skin and wound healing</article-title>. <source>Clin. Geriatr. Med.</source>
<volume>40</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cger.2023.06.001</pub-id>
<pub-id pub-id-type="pmid">38000854</pub-id>
</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kwon</surname><given-names>M.</given-names></name><name><surname>Oh</surname><given-names>N.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Seo</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Cell-penetrating peptides enhance the activity of human fibroblast growth factor 2 by prolonging the retention time: a new vision for drug-delivery systems</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>21</volume>, <fpage>442</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21020442</pub-id>
<pub-id pub-id-type="pmid">32284513</pub-id>
</mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lei</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Lv</surname><given-names>Q.</given-names></name></person-group> (<year>2022</year>). <article-title>Current understanding of hydrogel for drug release and tissue engineering</article-title>. <source>Gels</source>
<volume>8</volume>, <fpage>301</fpage>. <pub-id pub-id-type="doi">10.3390/gels8050301</pub-id>
<pub-id pub-id-type="pmid">35621599</pub-id>
</mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Umbilical cord&#x02010;derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: from mechanism to therapeutics</article-title>. <source>Cell Prolif.</source>
<volume>57</volume>, <fpage>e13586</fpage>. <pub-id pub-id-type="doi">10.1111/cpr.13586</pub-id>
<pub-id pub-id-type="pmid">38148579</pub-id>
</mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway</article-title>. <source>Stem Cell Res. and Ther.</source>
<volume>7</volume> (<issue>1</issue>), <fpage>102</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-016-0356-6</pub-id>
<pub-id pub-id-type="pmid">27484727</pub-id>
</mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>P.-H.</given-names></name><name><surname>Sermersheim</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>P. H. U.</given-names></name><name><surname>Steinberg</surname><given-names>S. M.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Zinc in wound healing modulation</article-title>. <source>Nutrients</source>
<volume>10</volume> (<issue>1</issue>), <fpage>16</fpage>. <pub-id pub-id-type="doi">10.3390/nu10010016</pub-id>
<pub-id pub-id-type="pmid">29295546</pub-id>
</mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.-K.</given-names></name></person-group> (<year>2022</year>). <article-title>Natural products in cosmetics</article-title>. <source>Nat. Prod. Bioprospecting</source>
<volume>12</volume> (<issue>1</issue>), <fpage>40</fpage>. <pub-id pub-id-type="doi">10.1007/s13659-022-00363-y</pub-id>
</mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>J.-M.</given-names></name><name><surname>Gan</surname><given-names>Y.-C.</given-names></name><name><surname>Qiu</surname><given-names>X.-Z.</given-names></name><name><surname>Gao</surname><given-names>Z.-C.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications</article-title>. <source>Mil. Med. Res.</source>
<volume>10</volume>, <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/s40779-023-00448-w</pub-id>
<pub-id pub-id-type="pmid">36978167</pub-id>
</mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Michael</surname><given-names>S.</given-names></name><name><surname>Bharti</surname><given-names>K.</given-names></name><name><surname>Ferrer</surname><given-names>M.</given-names></name><name><surname>Song</surname><given-names>M. J.</given-names></name></person-group> (<year>2020</year>). <article-title>A biofabricated vascularized skin model of atopic dermatitis for preclinical studies</article-title>. <source>Biofabrication</source>
<volume>12</volume> (<issue>3</issue>), <fpage>035002</fpage>. <pub-id pub-id-type="doi">10.1088/1758-5090/ab76a1</pub-id>
<pub-id pub-id-type="pmid">32059197</pub-id>
</mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loke</surname><given-names>A. S. W.</given-names></name><name><surname>Longley</surname><given-names>B. J.</given-names></name><name><surname>Lambert</surname><given-names>P. F.</given-names></name><name><surname>Spurgeon</surname><given-names>M. E.</given-names></name></person-group> (<year>2021</year>). <article-title>A novel <italic>in vitro</italic> culture model system to study merkel cell polyomavirus&#x02013;associated MCC using three-dimensional organotypic raft equivalents of human skin</article-title>. <source>Viruses</source>
<volume>13</volume> (<issue>1</issue>), <fpage>138</fpage>. <pub-id pub-id-type="doi">10.3390/v13010138</pub-id>
<pub-id pub-id-type="pmid">33478104</pub-id>
</mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lorthois</surname><given-names>I.</given-names></name><name><surname>Simard</surname><given-names>M.</given-names></name><name><surname>Morin</surname><given-names>S.</given-names></name><name><surname>Pouliot</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Infiltration of T Cells into a three-dimensional psoriatic skin model mimics pathological key features</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>20</volume> (<issue>7</issue>), <fpage>1670</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20071670</pub-id>
<pub-id pub-id-type="pmid">30987186</pub-id>
</mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lou</surname><given-names>Z.</given-names></name></person-group> (<year>2021</year>). <article-title>The effect of epidermal growth factor on the pseudo-healing of traumatic tympanic membrane perforations</article-title>. <source>Braz. J. Otorhinolaryngology</source>
<volume>87</volume> (<issue>1</issue>), <fpage>53</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjorl.2019.06.011</pub-id>
</mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loukelis</surname><given-names>K.</given-names></name><name><surname>Koutsomarkos</surname><given-names>N.</given-names></name><name><surname>Mikos</surname><given-names>A. G.</given-names></name><name><surname>Chatzinikolaidou</surname><given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Advances in 3D bioprinting for regenerative medicine applications</article-title>. <source>Regen. Biomater.</source>
<volume>11</volume>, <fpage>rbae033</fpage>. <pub-id pub-id-type="doi">10.1093/rb/rbae033</pub-id>
<pub-id pub-id-type="pmid">38845855</pub-id>
</mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Du</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Novel roles of bovine milk-derived exosomes in skin antiaging</article-title>. <source>J. Cosmet. Dermatology</source>
<volume>23</volume> (<issue>4</issue>), <fpage>1374</fpage>&#x02013;<lpage>1385</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.16112</pub-id>
</mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lukomskyj</surname><given-names>A. O.</given-names></name><name><surname>Rao</surname><given-names>N.</given-names></name><name><surname>Yan</surname><given-names>L.</given-names></name><name><surname>Pye</surname><given-names>J. S.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Stem cell-based tissue engineering for the treatment of burn wounds: a systematic review of preclinical studies</article-title>. <source>Stem Cell Rev. And Rep.</source>
<volume>18</volume> (<issue>6</issue>), <fpage>1926</fpage>&#x02013;<lpage>1955</lpage>. <pub-id pub-id-type="doi">10.1007/s12015-022-10341-z</pub-id>
<pub-id pub-id-type="pmid">35150392</pub-id>
</mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zeng</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Potential genetic therapies based on m6A methylation for skin regeneration: wound healing and scars/keloids</article-title>. <source>Front. Bioeng. Biotechnol.</source>
<volume>11</volume> (<issue>April</issue>), <fpage>1143866</fpage>&#x02013;<lpage>1143867</lpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2023.1143866</pub-id>
<pub-id pub-id-type="pmid">37122849</pub-id>
</mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Siu</surname><given-names>W. S.</given-names></name><name><surname>Leung</surname><given-names>P. C.</given-names></name></person-group> (<year>2023</year>). <article-title>The potential of MSC-based cell-free therapy in wound healing&#x02014;a thorough literature review</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>24</volume> (<issue>11</issue>), <fpage>9356</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24119356</pub-id>
<pub-id pub-id-type="pmid">37298306</pub-id>
</mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mahajan</surname><given-names>N.</given-names></name><name><surname>Soker</surname><given-names>S.</given-names></name><name><surname>Murphy</surname><given-names>S. V.</given-names></name></person-group> (<year>2024</year>). <article-title>Regenerative medicine approaches for skin wound healing: from allografts to engineered skin substitutes</article-title>. <source>Curr. Transpl. Rep.</source>
<volume>11</volume>, <fpage>207</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1007/s40472-024-00453-5</pub-id>
</mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maio</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Myomodulation with injectable fillers: an innovative approach to addressing facial muscle movement</article-title>. <source>AestheticPlast. Surg.</source>
<volume>42</volume>, <fpage>798</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1007/s00266-018-1116-z</pub-id>
</mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Makpol</surname><given-names>S.</given-names></name><name><surname>Jam</surname><given-names>F. A.</given-names></name><name><surname>Khor</surname><given-names>S. C.</given-names></name><name><surname>Ismail</surname><given-names>Z.</given-names></name><name><surname>Mohd Yusof</surname><given-names>Y. A.</given-names></name><name><surname>Wan Ngah</surname><given-names>W. Z.</given-names></name></person-group> (<year>2013</year>). <article-title>Comparative effects of biodynes, tocotrienol-rich fraction, and tocopherol in enhancing collagen synthesis and inhibiting collagen degradation in stress-induced premature senescence model of human diploid fibroblasts</article-title>. <source>Oxidative Med. andCellular Longev.</source>
<volume>2013</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1155/2013/298574</pub-id>
</mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mao</surname><given-names>A. S.</given-names></name><name><surname>Mooney</surname><given-names>D. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Regenerative medicine: current therapies and future directions</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>112</volume> (<issue>47</issue>), <fpage>14452</fpage>&#x02013;<lpage>14459</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1508520112</pub-id>
<pub-id pub-id-type="pmid">26598661</pub-id>
</mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matai</surname><given-names>I.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Seyedsalehi</surname><given-names>A.</given-names></name><name><surname>McClinton</surname><given-names>A.</given-names></name><name><surname>Laurencin</surname><given-names>C. T.</given-names></name></person-group> (<year>2020</year>). <article-title>Progress in 3D bioprinting technology for tissue/organ regenerative engineering</article-title>. <source>Biomaterials</source>
<volume>226</volume> (<issue>September 2019</issue>), <fpage>119536</fpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2019.119536</pub-id>
<pub-id pub-id-type="pmid">31648135</pub-id>
</mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazini</surname><given-names>L.</given-names></name><name><surname>Rochette</surname><given-names>L.</given-names></name><name><surname>Admou</surname><given-names>B.</given-names></name><name><surname>Amal</surname><given-names>S.</given-names></name><name><surname>Malka</surname><given-names>G.</given-names></name></person-group> (<year>2020</year>). <article-title>Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>21</volume> (<issue>4</issue>), <fpage>1306</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21041306</pub-id>
<pub-id pub-id-type="pmid">32075181</pub-id>
</mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miguel</surname><given-names>S. P.</given-names></name><name><surname>Cabral</surname><given-names>C. S. D.</given-names></name><name><surname>Moreira</surname><given-names>A. F.</given-names></name><name><surname>Correia</surname><given-names>I. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Production and characterization of a novel asymmetric 3D printed construct aimed for skin tissue regeneration</article-title>. <source>Colloids Surfaces B Biointerfaces</source>
<volume>181</volume> (<issue>June</issue>), <fpage>994</fpage>&#x02013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2019.06.063</pub-id>
<pub-id pub-id-type="pmid">31382351</pub-id>
</mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller-Kobisher</surname><given-names>B.</given-names></name><name><surname>Su&#x000e1;rez-Vega</surname><given-names>D.</given-names></name><name><surname>Velazco De Maldonado</surname><given-names>G.</given-names></name></person-group> (<year>2021</year>). <article-title>Epidermal growth factor in aesthetics and regenerative medicine: systematic review</article-title>. <source>J. Cutan. Aesthetic Surg.</source>
<volume>14</volume> (<issue>2</issue>), <fpage>137</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.4103/JCAS.JCAS_25_20</pub-id>
</mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monavarian</surname><given-names>M.</given-names></name><name><surname>Kader</surname><given-names>S.</given-names></name><name><surname>Moeinzadeh</surname><given-names>S.</given-names></name><name><surname>Jabbari</surname><given-names>E.</given-names></name></person-group> (<year>2019</year>). <article-title>Regenerative scar-free skin wound healing</article-title>. <source>Tissue Eng. Part B Rev.</source>
<volume>25</volume>, <fpage>294</fpage>&#x02013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1089/ten.teb.2018.0350</pub-id>
<pub-id pub-id-type="pmid">30938269</pub-id>
</mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narayanaswamy</surname><given-names>R.</given-names></name><name><surname>Patro</surname><given-names>B. P.</given-names></name><name><surname>Jeyaraman</surname><given-names>N.</given-names></name><name><surname>Gangadaran</surname><given-names>P.</given-names></name><name><surname>Rajendran</surname><given-names>R. L.</given-names></name><name><surname>Nallakumarasamy</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Evolution and clinical advances of platelet-rich fibrin in musculoskeletal regeneration</article-title>. <source>Bioengineering</source>
<volume>10</volume>, <fpage>58</fpage>. <pub-id pub-id-type="doi">10.3390/bioengineering10010058</pub-id>
<pub-id pub-id-type="pmid">36671630</pub-id>
</mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>H. M.</given-names></name><name><surname>Ngoc Le</surname><given-names>T. T.</given-names></name><name><surname>Nguyen</surname><given-names>A. T.</given-names></name><name><surname>Thien Le</surname><given-names>H. N.</given-names></name><name><surname>Pham</surname><given-names>T. T.</given-names></name></person-group> (<year>2023</year>). <article-title>Biomedical materials for wound dressing: recent advances and applications</article-title>. <source>RSC Adv.</source>
<volume>13</volume> (<issue>8</issue>), <fpage>5509</fpage>&#x02013;<lpage>5528</lpage>. <pub-id pub-id-type="doi">10.1039/d2ra07673j</pub-id>
<pub-id pub-id-type="pmid">36793301</pub-id>
</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Nqoro</surname><given-names>X.</given-names></name><name><surname>Alven</surname><given-names>S.</given-names></name><name><surname>Buyana</surname><given-names>B.</given-names></name><name><surname>Feketshane</surname><given-names>Z.</given-names></name><name><surname>Aderibigbe</surname><given-names>B. A.</given-names></name></person-group> (<year>2022</year>). &#x0201c;<article-title>Alginate-based wound dressings for skin healing and regeneration</article-title>,&#x0201d; in <source>Natural polymers in wound healing and repair</source> (<publisher-name>Elsevier</publisher-name>), <fpage>381</fpage>&#x02013;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-323-90514-5.00004-3</pub-id>
</mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohguro</surname><given-names>H.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Hikage</surname><given-names>F.</given-names></name><name><surname>Furuhashi</surname><given-names>M.</given-names></name><name><surname>Okura</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>3D spheroid configurations are possible indictors for evaluating the pathophysiology of melanoma cell lines</article-title>. <source>Cells</source>
<volume>12</volume> (<issue>5</issue>), <fpage>759</fpage>. <pub-id pub-id-type="doi">10.3390/cells12050759</pub-id>
<pub-id pub-id-type="pmid">36899895</pub-id>
</mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohguro</surname><given-names>H.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Nishikiori</surname><given-names>N.</given-names></name><name><surname>Umetsu</surname><given-names>A.</given-names></name><name><surname>Higashide</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Application of single cell type-derived spheroids generated by using a hanging drop culture technique in various <italic>in vitro</italic> disease models: a narrow review</article-title>. <source>Cells</source>
<volume>13</volume>, <fpage>1549</fpage>. <pub-id pub-id-type="doi">10.3390/cells13181549</pub-id>
<pub-id pub-id-type="pmid">39329734</pub-id>
</mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>OuYang</surname><given-names>H.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Ren</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review</article-title>. <source>Front. Endocrinol. (Lausanne)</source>
<volume>14</volume>, <fpage>1256081</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2023.1256081</pub-id>
<pub-id pub-id-type="pmid">38169990</pub-id>
</mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paganelli</surname><given-names>A.</given-names></name><name><surname>Tarentini</surname><given-names>E.</given-names></name><name><surname>Benassi</surname><given-names>L.</given-names></name><name><surname>Kaleci</surname><given-names>S.</given-names></name><name><surname>Magnoni</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review</article-title>. <source>Clin. And Exp. Dermatology</source>
<volume>45</volume> (<issue>7</issue>), <fpage>824</fpage>&#x02013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1111/ced.14269</pub-id>
</mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pamela</surname><given-names>R. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Topical growth factors for the treatment of facial photoaging: a clinical experience of eight cases</article-title>. <source>J. Ofclinical. Dermatology</source>
<volume>11</volume> (<issue>12</issue>), <fpage>28</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>A. Y.</given-names></name><name><surname>Lee</surname><given-names>J. O. K.</given-names></name><name><surname>Jang</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name><name><surname>Lee</surname><given-names>J. M. I. N.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Exosomes derived from human dermal fibroblasts protect against UVB-induced skin photoaging</article-title>. <source>Int. J. Mol. Med.</source>
<volume>52</volume> (<issue>6</issue>), <fpage>120</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2023.5323</pub-id>
<pub-id pub-id-type="pmid">37888610</pub-id>
</mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>H. S.</given-names></name><name><surname>Son</surname><given-names>H. Y.</given-names></name><name><surname>Choi</surname><given-names>M. H.</given-names></name><name><surname>Son</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Hong</surname><given-names>H. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Adipose-derived stem cells attenuate atopic dermatitis-like skin lesions in NC/Nga mice</article-title>. <source>Exp. Dermatol.</source>
<volume>28</volume> (<issue>3</issue>), <fpage>300</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1111/exd.13895</pub-id>
<pub-id pub-id-type="pmid">30688372</pub-id>
</mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parrado</surname><given-names>C.</given-names></name><name><surname>Mercado-Saenz</surname><given-names>S.</given-names></name><name><surname>Perez-Davo</surname><given-names>A.</given-names></name><name><surname>Gilaberte</surname><given-names>Y.</given-names></name><name><surname>Gonzalez</surname><given-names>S.</given-names></name><name><surname>&#x00026;Juarranz</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Environmental stressors on skin aging. Mechanistic insights</article-title>. <source>Front. Pharmacol.</source>
<volume>10</volume> (<issue>July</issue>), <fpage>759</fpage>&#x02013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00759</pub-id>
<pub-id pub-id-type="pmid">31354480</pub-id>
</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pasierb</surname><given-names>A.</given-names></name><name><surname>Jezierska</surname><given-names>M.</given-names></name><name><surname>Karpuk</surname><given-names>A.</given-names></name><name><surname>Czuwara</surname><given-names>J.</given-names></name><name><surname>Rudnicka</surname><given-names>L.</given-names></name></person-group> (<year>2022</year>). <article-title>3D skin bioprinting: future potential for skin regeneration</article-title>. <source>PostepyDermatologiiiAlergologii</source>
<volume>39</volume> (<issue>5</issue>), <fpage>845</fpage>&#x02013;<lpage>851</lpage>. <pub-id pub-id-type="doi">10.5114/ada.2021.109692</pub-id>
</mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pe&#x000f1;a</surname><given-names>O. A.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name></person-group> (<year>2024</year>). <article-title>Cellular and molecular mechanisms of skin wound healing</article-title>. <source>NatureReviews Mol. Cell Biol.</source>
<volume>25</volume> (<issue>8</issue>), <fpage>599</fpage>&#x02013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-024-00715-1</pub-id>
</mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phoebe</surname><given-names>L. K. W.</given-names></name><name><surname>Lee</surname><given-names>K. W. A.</given-names></name><name><surname>Chan</surname><given-names>L. K. W.</given-names></name><name><surname>Hung</surname><given-names>L. C.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Wong</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Use of platelet rich plasma for skin rejuvenation</article-title>. <source>Skin Res. Technol.</source>
<volume>30</volume> (<issue>4</issue>), <fpage>e13714</fpage>&#x02013;<lpage>e13716</lpage>. <pub-id pub-id-type="doi">10.1111/srt.13714</pub-id>
<pub-id pub-id-type="pmid">38650371</pub-id>
</mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pican&#x000e7;o-Castro</surname><given-names>V.</given-names></name><name><surname>Pereira</surname><given-names>C. G.</given-names></name><name><surname>Covas</surname><given-names>D. T.</given-names></name><name><surname>Porto</surname><given-names>G. S.</given-names></name><name><surname>Athanassiadou</surname><given-names>A.</given-names></name><name><surname>Figueiredo</surname><given-names>M. L.</given-names></name></person-group> (<year>2020</year>). <article-title>Emerging patent landscape for non-viral vectors used for gene therapy</article-title>. <source>NatureBiotechnology</source>
<volume>38</volume> (<issue>2</issue>), <fpage>151</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0402-x</pub-id>
</mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pincelli</surname><given-names>T. P.</given-names></name><name><surname>Zawawi</surname><given-names>S.</given-names></name><name><surname>Shapiro</surname><given-names>S. A.</given-names></name><name><surname>Heckman</surname><given-names>M. G.</given-names></name><name><surname>Hochwald</surname><given-names>A. P.</given-names></name><name><surname>Arthurs</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Evaluation of platelet-rich plasma and microneedling for facial skin rejuvenation</article-title>. <source>Plast. Reconstr. Surg. - Glob. Open</source>
<volume>12</volume>, <fpage>e5829</fpage>. <pub-id pub-id-type="doi">10.1097/GOX.0000000000005829</pub-id>
<pub-id pub-id-type="pmid">38798929</pub-id>
</mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pino</surname><given-names>P.</given-names></name><name><surname>Bosco</surname><given-names>F.</given-names></name><name><surname>Mollea</surname><given-names>C.</given-names></name><name><surname>Onida</surname><given-names>B.</given-names></name></person-group> (<year>2023</year>). <article-title>Antimicrobial nano-zinc oxide biocomposites for wound healing applications: a review</article-title>. <source>Pharmaceutics</source>
<volume>15</volume>, <fpage>970</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics15030970</pub-id>
<pub-id pub-id-type="pmid">36986831</pub-id>
</mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pixley</surname><given-names>J. N.</given-names></name><name><surname>Cook</surname><given-names>M. K.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Larrondo</surname><given-names>J.</given-names></name><name><surname>McMichael</surname><given-names>A. J.</given-names></name></person-group> (<year>2023</year>). <article-title>A comprehensive review of platelet-rich plasma for the treatment of dermatologic disorders</article-title>. <source>J. Dermatol. Treat.</source>
<volume>34</volume>, <fpage>2142035</fpage>. <pub-id pub-id-type="doi">10.1080/09546634.2022.2142035</pub-id>
</mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pleguezuelos-Beltr&#x000e1;n</surname><given-names>P.</given-names></name><name><surname>Herr&#x000e1;iz-Gil</surname><given-names>S.</given-names></name><name><surname>Mart&#x000ed;nez-Moreno</surname><given-names>D.</given-names></name><name><surname>Medra&#x000f1;o-Fernandez</surname><given-names>I.</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>C.</given-names></name><name><surname>Guerrero-Aspizua</surname><given-names>S.</given-names></name></person-group> (<year>2024</year>). <article-title>Regenerative cosmetics: skin tissue engineering for anti-aging, repair, and hair restoration</article-title>. <source>Cosmetics</source>
<volume>11</volume> (<issue>4</issue>), <fpage>121</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.3390/cosmetics11040121</pub-id>
</mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Portugal-Cohen</surname><given-names>M.</given-names></name><name><surname>Cohen</surname><given-names>D.</given-names></name><name><surname>Kohen</surname><given-names>R.</given-names></name><name><surname>Oron</surname><given-names>M.</given-names></name></person-group> (<year>2023</year>). <article-title>Exploitation of alternative skin models from academia to industry: proposed functional categories to answer needs and regulation demands</article-title>. <source>Front. Physiol.</source>
<volume>14</volume>, <fpage>1215266</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2023.1215266</pub-id>
<pub-id pub-id-type="pmid">37334052</pub-id>
</mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prasai</surname><given-names>A.</given-names></name><name><surname>Jay</surname><given-names>J. W.</given-names></name><name><surname>Jupiter</surname><given-names>D.</given-names></name><name><surname>Wolf</surname><given-names>S. E.</given-names></name><name><surname>El Ayadi</surname><given-names>A.</given-names></name></person-group> (<year>2022</year>). <article-title>Role of exosomes in dermal wound healing: a systematic review</article-title>. <source>J. Investigative Dermatology</source>
<volume>142</volume> (<issue>3</issue>), <fpage>662</fpage>&#x02013;<lpage>678.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2021.07.167</pub-id>
</mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quan</surname><given-names>T.</given-names></name></person-group> (<year>2023</year>). <article-title>Human skin aging and the anti-aging properties of retinol</article-title>. <source>Biomolecules</source>
<volume>13</volume> (<issue>11</issue>), <fpage>1614</fpage>. <pub-id pub-id-type="doi">10.3390/biom13111614</pub-id>
<pub-id pub-id-type="pmid">38002296</pub-id>
</mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>D. J.</given-names></name><name><surname>Ghanem</surname><given-names>A. M.</given-names></name><name><surname>Hassan</surname><given-names>H.</given-names></name></person-group> (<year>2023</year>). <article-title>Topical growth factor preparations for facial skin rejuvenation: a systematic review</article-title>. <source>J. Cosmet. Dermatology</source>
<volume>22</volume> (<issue>7</issue>), <fpage>2023</fpage>&#x02013;<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1111/jocd.15644</pub-id>
</mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raghavan</surname><given-names>S.</given-names></name><name><surname>Mehta</surname><given-names>P.</given-names></name><name><surname>Horst</surname><given-names>E. N.</given-names></name><name><surname>Ward</surname><given-names>M. R.</given-names></name><name><surname>Rowley</surname><given-names>K. R.</given-names></name><name><surname>Mehta</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Comparative analysis of tumor spheroid generation techniques for differential <italic>in vitro</italic> drug toxicity</article-title>. <source>Oncotarget</source>
<volume>7</volume> (<issue>13</issue>), <fpage>16948</fpage>&#x02013;<lpage>16961</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.7659</pub-id>
<pub-id pub-id-type="pmid">26918944</pub-id>
</mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raju</surname><given-names>N.</given-names></name><name><surname>Silina</surname><given-names>E.</given-names></name><name><surname>Stupin</surname><given-names>V.</given-names></name><name><surname>Manturova</surname><given-names>N.</given-names></name><name><surname>Chidambaram</surname><given-names>S. B.</given-names></name><name><surname>Achar</surname><given-names>R. R.</given-names></name></person-group> (<year>2022</year>). <article-title>Multifunctional and smart wound dressings&#x02014;a review on recent research advancements in skin regenerative medicine</article-title>. <source>Pharmaceutics</source>
<volume>14</volume> (<issue>8</issue>), <fpage>1</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics14081574</pub-id>
</mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Randall</surname><given-names>M. J.</given-names></name><name><surname>J&#x000fc;ngel</surname><given-names>A.</given-names></name><name><surname>Rimann</surname><given-names>M.</given-names></name><name><surname>&#x00026;Wuertz-Kozak</surname><given-names>K.</given-names></name></person-group> (<year>2018</year>). <article-title>Advances in the biofabrication of 3D skin <italic>in vitro</italic>: healthy and pathological models</article-title>. <source>Front. Bioeng. Biotechnol.</source>
<volume>6</volume> (<issue>OCT</issue>), <fpage>154</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2018.00154</pub-id>
<pub-id pub-id-type="pmid">30430109</pub-id>
</mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rezaie</surname><given-names>J.</given-names></name><name><surname>Feghhi</surname><given-names>M.</given-names></name><name><surname>Etemadi</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>A review on exosomes application in clinical trials: perspective, questions, and challenges</article-title>. <source>Cell Commun. Signal.</source>
<volume>20</volume> (<issue>1</issue>), <fpage>145</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1186/s12964-022-00959-4</pub-id>
<pub-id pub-id-type="pmid">36123730</pub-id>
</mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ribaudo</surname><given-names>G.</given-names></name><name><surname>Gianoncelli</surname><given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>An updated overview on the role of small molecules and natural compounds in the &#x0201c;young science&#x0201d; of rejuvenation</article-title>. <source>Antioxidants</source>
<volume>12</volume> (<issue>2</issue>), <fpage>288</fpage>. <pub-id pub-id-type="doi">10.3390/antiox12020288</pub-id>
<pub-id pub-id-type="pmid">36829846</pub-id>
</mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roohaninasab</surname><given-names>M.</given-names></name><name><surname>Khodadad</surname><given-names>F.</given-names></name><name><surname>Sadeghzadeh-Bazargan</surname><given-names>A.</given-names></name><name><surname>Atefi</surname><given-names>N.</given-names></name><name><surname>Zare</surname><given-names>S.</given-names></name><name><surname>Jafarzadeh</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Efficacy of fractional CO2 laser in combination with stromal vascular fraction (SVF) compared with fractional CO2 laser alone in the treatment of burn scars: a randomized controlled clinical trial</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>269</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1186/s13287-023-03480-8</pub-id>
<pub-id pub-id-type="pmid">37742019</pub-id>
</mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salehi</surname><given-names>S.</given-names></name><name><surname>Koeck</surname><given-names>K.</given-names></name><name><surname>Scheibel</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Spider silk for tissue engineering applications</article-title>. <source>Molecules</source>
<volume>25</volume> (<issue>3</issue>), <fpage>737</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25030737</pub-id>
<pub-id pub-id-type="pmid">32046280</pub-id>
</mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Samadi</surname><given-names>P.</given-names></name><name><surname>Sheykhhasan</surname><given-names>M.</given-names></name><name><surname>Khoshinani</surname><given-names>H. M.</given-names></name></person-group> (<year>2019</year>). <article-title>The use of platelet-rich plasma in aesthetic and regenerative medicine: a comprehensive review</article-title>. <source>AestheticPlasticSurgery</source>
<volume>43</volume> (<issue>3</issue>), <fpage>803</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1007/s00266-018-1293-9</pub-id>
</mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sampogna</surname><given-names>G.</given-names></name><name><surname>Guraya</surname><given-names>S. Y.</given-names></name><name><surname>Forgione</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Regenerative medicine: historical roots and potential strategies in modern medicine</article-title>. <source>J. ofMicroscopyandUltrastructure</source>
<volume>3</volume> (<issue>3</issue>), <fpage>101</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmau.2015.05.002</pub-id>
</mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santos</surname><given-names>J. F.</given-names></name><name><surname>Freitas-Marchi</surname><given-names>B. L.</given-names></name><name><surname>Reigado</surname><given-names>G. R.</given-names></name><name><surname>de Assis</surname><given-names>S. R.</given-names></name><name><surname>Maria Engler</surname><given-names>S. S.</given-names></name><name><surname>Chambergo Alcalde</surname><given-names>F. S.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Mesenchymal stem cells express epidermal markers in an <italic>in vitro</italic> reconstructed human skin model</article-title>. <source>Front. Cell Dev. Biol.</source>
<volume>10</volume>. <pub-id pub-id-type="doi">10.3389/fcell.2022.1012637</pub-id>
</mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sch&#x000e4;fer</surname><given-names>M.</given-names></name><name><surname>Klicks</surname><given-names>J.</given-names></name><name><surname>Hafner</surname><given-names>M.</given-names></name><name><surname>Rudolf</surname><given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Preparation, drug treatment, and immunohistological analysis of tri-culture spheroid 3D melanoma-like models</article-title>. <source>Methods Mol. Biol.</source>
<volume>2265</volume>, <fpage>173</fpage>&#x02013;<lpage>183</lpage>. <comment>PMID: 33704714</comment>. <pub-id pub-id-type="doi">10.1007/978-1-0716-1205-7_13</pub-id>
<pub-id pub-id-type="pmid">33704714</pub-id>
</mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Semsarzadeh</surname><given-names>N.</given-names></name><name><surname>Khetarpal</surname><given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Rise of stem cell therapies in aesthetics</article-title>. <source>Clin. Dermatol</source>
<volume>40</volume>, <fpage>49</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.clindermatol.2021.08.012</pub-id>
<pub-id pub-id-type="pmid">35190065</pub-id>
</mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Ntege</surname><given-names>E. H.</given-names></name><name><surname>Sunami</surname><given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>Current regenerative medicine-based approaches for skin regeneration: a review of literature and a report on clinical applications in Japan</article-title>. <source>RegenTher</source>
<volume>21</volume>, <fpage>73</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.reth.2022.05.008</pub-id>
</mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>T.-H.</given-names></name><name><surname>Kim</surname><given-names>H.-S.</given-names></name><name><surname>Choi</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>K.-S.</given-names></name></person-group> (<year>2017</year>). <article-title>Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>18</volume>, <fpage>244</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18020244</pub-id>
<pub-id pub-id-type="pmid">28125063</pub-id>
</mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smolinsk&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Boh&#x000e1;&#x0010d;</surname><given-names>M.</given-names></name><name><surname>Dani&#x00142;ovi&#x0010d;</surname><given-names>&#x0013d;.</given-names></name></person-group> (<year>2023</year>). <article-title>Current status of the applications of conditioned media derived from mesenchymal stem cells for regenerative medicine</article-title>. <source>Physiological Research</source>
<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.33549/physiolres.935186</pub-id>
<pub-id pub-id-type="pmid">36545873</pub-id>
</mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sonbhadra</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>L. M.</given-names></name></person-group> (<year>2023</year>). <article-title>Biogenesis, isolation, and detection of exosomes and their potential in therapeutics and diagnostics</article-title>. <source>Biosens. (Basel)</source>
<volume>13</volume>, <fpage>802</fpage>. <pub-id pub-id-type="doi">10.3390/bios13080802</pub-id>
</mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>You</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Adipose&#x02010;derived mesenchymal stem cell&#x02010;derived exosomes biopotentiated extracellular matrix hydrogels accelerate diabetic wound healing and skin regeneration</article-title>. <source>Adv. Sci.</source>
<volume>10</volume>, <fpage>e2304023</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202304023</pub-id>
</mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suh</surname><given-names>A.</given-names></name><name><surname>Pham</surname><given-names>A.</given-names></name><name><surname>Cress</surname><given-names>M. J.</given-names></name><name><surname>Pincelli</surname><given-names>T.</given-names></name><name><surname>TerKonda</surname><given-names>S. P.</given-names></name><name><surname>Bruce</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation</article-title>. <source>Ageing Res. Rev.</source>
<volume>54</volume>, <fpage>100933</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2019.100933</pub-id>
<pub-id pub-id-type="pmid">31247326</pub-id>
</mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Surowiecka</surname><given-names>A.</given-names></name><name><surname>Stru&#x0017c;yna</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Adipose-derived stem cells for facial rejuvenation</article-title>. <source>J. PersMed</source>
<volume>12</volume>, <fpage>117</fpage>. <pub-id pub-id-type="doi">10.3390/jpm12010117</pub-id>
</mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Surowiecka</surname><given-names>A.</given-names></name><name><surname>Stru&#x0017c;yna</surname><given-names>J.</given-names></name><name><surname>Winiarska</surname><given-names>A.</given-names></name><name><surname>Korzeniowski</surname><given-names>T.</given-names></name></person-group> (<year>2022</year>). <article-title>Hydrogels in burn wound management&#x02014;a review</article-title>. <source>Gels.</source>
<volume>9</volume>, <fpage>37</fpage>. <pub-id pub-id-type="doi">10.3390/gels9010037</pub-id>
<pub-id pub-id-type="pmid">36661839</pub-id>
</mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suthar</surname><given-names>D.</given-names></name><name><surname>Raut</surname><given-names>R.</given-names></name><name><surname>Bajaj</surname><given-names>A.</given-names></name></person-group> (<year>2024</year>). <article-title>Advances in skin-mimetic platforms: a comprehensive review of drug permeation models</article-title>. <source>J. Drug Deliv. Sci. Technol.</source>
<volume>98</volume>, <fpage>105887</fpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2024.105887</pub-id>
</mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tamayol</surname><given-names>A.</given-names></name><name><surname>Akbari</surname><given-names>M.</given-names></name><name><surname>Zilberman</surname><given-names>Y.</given-names></name><name><surname>Comotto</surname><given-names>M.</given-names></name><name><surname>Lesha</surname><given-names>E.</given-names></name><name><surname>Serex</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Flexible pH&#x02010;sensing hydrogel fibers for epidermal applications</article-title>. <source>Adv. Healthc. Mater</source>
<volume>5</volume>, <fpage>711</fpage>&#x02013;<lpage>719</lpage>. <pub-id pub-id-type="doi">10.1002/adhm.201500553</pub-id>
<pub-id pub-id-type="pmid">26799457</pub-id>
</mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taub</surname><given-names>A. F.</given-names></name></person-group> (<year>2024</year>). <article-title>Regenerative topical skincare: stem cells and exosomes</article-title>. <source>Front. Med.</source>
<volume>11</volume>, <fpage>1443963</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2024.1443963</pub-id>
</mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tavakoli</surname><given-names>S.</given-names></name><name><surname>Klar</surname><given-names>A. S.</given-names></name></person-group> (<year>2020</year>). <article-title>Advanced hydrogels as wound dressings</article-title>. <source>Biomolecules</source>
<volume>10</volume>, <fpage>1169</fpage>. <pub-id pub-id-type="doi">10.3390/biom10081169</pub-id>
<pub-id pub-id-type="pmid">32796593</pub-id>
</mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tenchov</surname><given-names>R.</given-names></name><name><surname>Sasso</surname><given-names>J. M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Q. A.</given-names></name></person-group> (<year>2024</year>). <article-title>Anti aging strategies and remedies: a landscape of research progress and promise</article-title>. <source>ACS Chem. Neurosci.</source>
<volume>15</volume>, <fpage>408</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.3c00532</pub-id>
<pub-id pub-id-type="pmid">38214973</pub-id>
</mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torre</surname><given-names>R. S.</given-names></name><name><surname>Fern&#x000e1;ndez-Gonz&#x000e1;lez</surname><given-names>A.</given-names></name><name><surname>Qui&#x000f1;ones-Vico</surname><given-names>M. I.</given-names></name><name><surname>Montero-Vilchez</surname><given-names>T.</given-names></name><name><surname>Arias-Santiago</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Bioengineered skin intended as <italic>in vitro</italic> model for pharmacosmetics, skin disease study and environmental skin impact analysis</article-title>. <source>Biomedicines</source>
<volume>8</volume>, <fpage>464</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines8110464</pub-id>
<pub-id pub-id-type="pmid">33142704</pub-id>
</mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torres</surname><given-names>A.</given-names></name><name><surname>Rego</surname><given-names>L.</given-names></name><name><surname>Martins</surname><given-names>M. S.</given-names></name><name><surname>Ferreira</surname><given-names>M. S.</given-names></name><name><surname>Cruz</surname><given-names>M. T.</given-names></name><name><surname>Sousa</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>How to promote skin repair? In-depth look at pharmaceutical and cosmetic strategies</article-title>. <source>Pharmaceuticals</source>
<volume>16</volume>, <fpage>573</fpage>. <pub-id pub-id-type="doi">10.3390/ph16040573</pub-id>
<pub-id pub-id-type="pmid">37111330</pub-id>
</mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tran</surname><given-names>D.-K.</given-names></name><name><surname>Phuong</surname><given-names>T. N. T.</given-names></name><name><surname>Bui</surname><given-names>N.-L.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Looi</surname><given-names>Q. H.</given-names></name><name><surname>Koh</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Exploring the potential of stem cell-based therapy for aesthetic and plastic Surgery</article-title>. <source>IEEE RevBiomedEng</source>
<volume>16</volume>, <fpage>386</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1109/RBME.2021.3134994</pub-id>
</mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vaidyanathan</surname><given-names>L.</given-names></name></person-group> (<year>2021</year>). <article-title>Growth factors in wound healing &#x02013; a review</article-title>. <source>Biomed. Pharmacol. J.</source>
<volume>14</volume>, <fpage>1469</fpage>&#x02013;<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.13005/bpj/2249</pub-id>
</mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wan</surname><given-names>T.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name><name><surname>Ping</surname><given-names>Y.</given-names></name></person-group> (<year>2021</year>). <article-title>Microneedle-assisted genome editing: a transdermal strategy of targeting <italic>NLRP3</italic> by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders</article-title>. <source>SciAdv</source>
<volume>7</volume>, <fpage>eabe2888</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.abe2888</pub-id>
</mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name></person-group> (<year>2021a</year>). <article-title>Application of metal-based biomaterials in wound repair</article-title>. <source>EngineeredRegeneration</source>
<volume>2</volume>, <fpage>137</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.engreg.2021.09.005</pub-id>
</mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Jin</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Exosomes in chronic inflammatory skin diseases and skin tumors</article-title>. <source>Exp. Dermatol.</source>
<volume>28</volume>, <fpage>213</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1111/exd.13857</pub-id>
<pub-id pub-id-type="pmid">30537027</pub-id>
</mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Kapadia</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>F.</given-names></name><name><surname>Pereira</surname><given-names>R. F.</given-names></name><name><surname>Granja</surname><given-names>P. L.</given-names></name><etal/></person-group> (<year>2021b</year>). <article-title>Tissue-specific engineering: 3D bioprinting in regenerative medicine</article-title>. <source>J. Control. Release</source>
<volume>329</volume>, <fpage>237</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2020.11.044</pub-id>
<pub-id pub-id-type="pmid">33259853</pub-id>
</mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Three-dimensional bioprinting of tissue-engineered skin: biomaterials, fabrication techniques, challenging difficulties, and future directions: a review</article-title>. <source>Int. J. Biol. Macromol.</source>
<volume>266</volume>, <fpage>131281</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.131281</pub-id>
<pub-id pub-id-type="pmid">38641503</pub-id>
</mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weng</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>3D bioprinting for skin tissue engineering: current status and perspectives</article-title>. <source>J. Tissue Eng.</source>
<volume>12</volume>, <fpage>20417314211028574</fpage>. <pub-id pub-id-type="doi">10.1177/20417314211028574</pub-id>
<pub-id pub-id-type="pmid">34345398</pub-id>
</mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wong</surname><given-names>P. M.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>New insight into the role of exosomes in vitiligo</article-title>. <source>Autoimmun. Rev.</source>
<volume>19</volume>, <fpage>102664</fpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2020.102664</pub-id>
<pub-id pub-id-type="pmid">32942029</pub-id>
</mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wongprasert</surname><given-names>P.</given-names></name><name><surname>Dreiss</surname><given-names>C. A.</given-names></name><name><surname>Murray</surname><given-names>G.</given-names></name></person-group> (<year>2022</year>). <article-title>Evaluating hyaluronic acid dermal fillers: a critique of current characterization methods</article-title>. <source>Dermatol. Ther.</source>
<volume>35</volume>, <fpage>e15453</fpage>. <pub-id pub-id-type="doi">10.1111/dth.15453</pub-id>
<pub-id pub-id-type="pmid">35293660</pub-id>
</mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>S.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Yao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2024</year>). <article-title>The role and prospects of mesenchymal stem cells in skin repair and regeneration</article-title>. <source>Biomedicines</source>
<volume>12</volume>, <fpage>743</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines12040743</pub-id>
<pub-id pub-id-type="pmid">38672102</pub-id>
</mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Bi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Teng</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>R. J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application</article-title>. <source>Front. Pharmacol.</source>
<volume>11</volume>, <fpage>697</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.00697</pub-id>
<pub-id pub-id-type="pmid">32508641</pub-id>
</mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Lv</surname><given-names>W.</given-names></name><name><surname>Yi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>The novel mechanisms and applications of exosomes in dermatology and cutaneous medical aesthetics</article-title>. <source>Pharmacol. Res.</source>
<volume>166</volume>, <fpage>105490</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105490</pub-id>
<pub-id pub-id-type="pmid">33582246</pub-id>
</mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization</article-title>. <source>Burn. Trauma</source>
<volume>8</volume>, <fpage>tkaa028</fpage>. <pub-id pub-id-type="doi">10.1093/burnst/tkaa028</pub-id>
</mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamakawa</surname><given-names>S.</given-names></name><name><surname>Hayashida</surname><given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Advances in surgical applications of growth factors for wound healing</article-title>. <source>Burn. Trauma</source>
<volume>7</volume>, <fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s41038-019-0148-1</pub-id>
</mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yazdi</surname><given-names>M. K.</given-names></name><name><surname>Zare</surname><given-names>M.</given-names></name><name><surname>Khodadadi</surname><given-names>A.</given-names></name><name><surname>Seidi</surname><given-names>F.</given-names></name><name><surname>Sajadi</surname><given-names>S. M.</given-names></name><name><surname>Zarrintaj</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Polydopamine biomaterials for skin regeneration</article-title>. <source>ACS Biomater. Sci. Eng.</source>
<volume>8</volume>, <fpage>2196</fpage>&#x02013;<lpage>2219</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.1c01436</pub-id>
<pub-id pub-id-type="pmid">35649119</pub-id>
</mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>K.</given-names></name><name><surname>Winayanuwattikun</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Wan</surname><given-names>J.</given-names></name><name><surname>Vachatimanont</surname><given-names>V.</given-names></name><name><surname>Putri</surname><given-names>A. I.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Skin boosters: definitions and varied classifications</article-title>. <source>Skin Res. Technol.</source>
<volume>30</volume>, <fpage>e13627</fpage>. <pub-id pub-id-type="doi">10.1111/srt.13627</pub-id>
<pub-id pub-id-type="pmid">38481069</pub-id>
</mixed-citation></ref><ref id="B183"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Yousef</surname><given-names>H.</given-names></name><name><surname>Alhajj</surname><given-names>M.</given-names></name><name><surname>Fakoya</surname><given-names>A. O.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name></person-group> (<year>2024</year>). <source>
<italic>Anatomy, skin (integument), epidermis</italic>. StatPearls. Treasure island (FL)</source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>. <comment>Available at: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/30817191" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/30817191</ext-link>.</comment>
</mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Exosomes: the emerging mechanisms and potential clinical applications in dermatology</article-title>. <source>Int. J. BiolSci</source>
<volume>20</volume>, <fpage>1778</fpage>&#x02013;<lpage>1795</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.92897</pub-id>
</mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Gene therapy strategies targeting aging-related diseases</article-title>. <source>AgingDis</source>
<volume>14</volume>, <fpage>398</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2022.00725</pub-id>
</mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Shan</surname><given-names>M.</given-names></name><name><surname>Hao</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Meng</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Convergence of 3D bioprinting and nanotechnology in tissue engineering scaffolds</article-title>. <source>Biomimetics</source>
<volume>8</volume>, <fpage>94</fpage>. <pub-id pub-id-type="doi">10.3390/biomimetics8010094</pub-id>
<pub-id pub-id-type="pmid">36975324</pub-id>
</mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Lu</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose</article-title>. <source>PLoS One</source>
<volume>9</volume>, <fpage>e97573</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0097573</pub-id>
<pub-id pub-id-type="pmid">24831697</pub-id>
</mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name></person-group> (<year>2023</year>). <article-title>Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications</article-title>. <source>Inflamm. Regen.</source>
<volume>43</volume>, <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/s41232-023-00287-1</pub-id>
<pub-id pub-id-type="pmid">37391780</pub-id>
</mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Gong</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing</article-title>. <source>Stem Cell Res. Ther.</source>
<volume>14</volume>, <fpage>107</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-023-03345-0</pub-id>
<pub-id pub-id-type="pmid">37101197</pub-id>
</mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>G.</given-names></name><name><surname>Ronca</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Amora</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Advanced application of collagen-based biomaterials in tissue repair and restoration</article-title>. <source>J. Leather Sci. Eng.</source>
<volume>4</volume>, <fpage>30</fpage>. <pub-id pub-id-type="doi">10.1186/s42825-022-00102-6</pub-id>
</mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Gou</surname><given-names>M.</given-names></name><name><surname>Mei</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>3D printing of functional biomaterials for tissue engineering</article-title>. <source>CurrOpin Biotechnol.</source>
<volume>40</volume>, <fpage>103</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2016.03.014</pub-id>
</mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zieli&#x00144;ski</surname><given-names>P. S.</given-names></name><name><surname>Gudeti</surname><given-names>P. K. R.</given-names></name><name><surname>Rikmanspoel</surname><given-names>T.</given-names></name><name><surname>W&#x00142;odarczyk-Biegun</surname><given-names>M. K.</given-names></name></person-group> (<year>2023</year>). <article-title>3D printing of bio-instructive materials: toward directing the cell</article-title>. <source>BioactMater</source>
<volume>19</volume>, <fpage>292</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioactmat.2022.04.008</pub-id>
</mixed-citation></ref></ref-list></back></article>